Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Sep. 30, 2018 | Oct. 31, 2018 | |
Document And Entity Information [Abstract] | ||
Entity Registrant Name | REGIONAL HEALTH PROPERTIES, INC. | |
Entity Central Index Key | 1,004,724 | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2018 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Common Stock, Shares Outstanding | 20,187,240 | |
Document Fiscal Year Focus | 2,018 | |
Document Fiscal Period Focus | Q3 | |
Trading Symbol | RHE | |
Entity Small Business | true | |
Entity Emerging Growth Company | false |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Current assets: | ||
Cash | $ 1,884 | $ 1,818 |
Restricted cash | 1,109 | 960 |
Accounts receivable, net of allowance of $1,414 and $2,570 | 887 | 945 |
Prepaid expenses and other | 263 | 304 |
Notes receivable | 829 | 677 |
Total current assets | 4,972 | 4,704 |
Restricted cash | 2,630 | 2,581 |
Property and equipment, net | 78,574 | 81,213 |
Intangible assets - bed licenses | 2,471 | 2,471 |
Intangible assets - lease rights, net | 1,586 | 2,187 |
Goodwill | 2,105 | 2,105 |
Lease deposits and other deposits | 936 | 808 |
Straight-line rent receivable | 6,632 | 6,400 |
Notes receivable | 1,361 | 3,540 |
Other assets | 71 | 542 |
Total assets | 101,338 | 106,551 |
Current liabilities: | ||
Current portion of notes payable and other debt | 25,744 | 6,621 |
Current portion of convertible debt, net | 1,469 | |
Accounts payable | 4,502 | 4,386 |
Accrued expenses and other | 4,220 | 7,022 |
Total current liabilities | 34,466 | 19,498 |
Notes payable and other debt, net of current portion: | ||
Senior debt, net | 48,645 | 57,801 |
Bonds, net | 6,519 | 6,567 |
Other debt, net | 644 | |
Other liabilities | 3,927 | 4,133 |
Deferred tax liabilities | 38 | 38 |
Total liabilities | 93,595 | 88,681 |
Commitments and contingencies (Note 13) | ||
Stockholders’ equity: | ||
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 20,187 and 19,697 issued and outstanding at September 30, 2018 and December 31, 2017, respectively | 61,850 | 61,724 |
Preferred stock, no par value; 5,000 shares authorized; 2,812 and 2,812 shares issued and outstanding, redemption amount $70,288 and $70,288 at September 30, 2018 and December 31, 2017, respectively | 62,423 | 62,423 |
Accumulated deficit | (116,530) | (106,277) |
Total stockholders’ equity | 7,743 | 17,870 |
Total liabilities and stockholders’ equity | $ 101,338 | $ 106,551 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Statement Of Financial Position [Abstract] | ||
Accounts receivable, allowance | $ 1,414 | $ 2,570 |
Common stock and additional paid-in capital, par value | $ 0 | $ 0 |
Common stock and additional paid-in capital, shares authorized | 55,000,000 | 55,000,000 |
Common stock and additional paid-in capital, shares issued | 20,187,000 | 19,697,000 |
Common stock and additional paid-in capital, shares outstanding | 20,187,000 | 19,697,000 |
Preferred stock, par value | $ 0 | $ 0 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | 2,812,000 | 2,812,000 |
Preferred stock, shares outstanding | 2,812,000 | 2,812,000 |
Preferred stock, redemption amount | $ 70,288 | $ 70,288 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Revenues: | ||||
Rental revenues | $ 4,972 | $ 5,983 | $ 15,706 | $ 17,703 |
Total revenues | 5,256 | 6,345 | 16,557 | 18,784 |
Expenses: | ||||
Facility rent expense | 2,171 | 2,171 | 6,512 | 6,512 |
Cost of management fees | 137 | 155 | 448 | 499 |
Depreciation and amortization | 1,126 | 1,193 | 3,507 | 3,499 |
General and administrative expense | 984 | 908 | 2,751 | 3,008 |
Provision for doubtful accounts | (48) | 0 | 3,934 | 455 |
Other operating expenses | 255 | 517 | 823 | 940 |
Total expenses | 4,625 | 4,944 | 17,975 | 14,913 |
Income (loss) from operations | 631 | 1,401 | (1,418) | 3,871 |
Other expense: | ||||
Interest expense, net | 1,783 | 1,011 | 4,595 | 3,049 |
Loss on extinguishment of debt | 3,514 | 0 | 3,955 | 63 |
Other expense | 0 | 105 | 10 | 388 |
Total other expense, net | 5,297 | 1,116 | 8,560 | 3,500 |
(Loss) income from continuing operations before income taxes | (4,666) | 285 | (9,978) | 371 |
Income tax expense | 0 | 19 | 33 | 20 |
(Loss) income from continuing operations | (4,666) | 266 | (10,011) | 351 |
Income (loss) from discontinued operations, net of tax | 157 | (1,032) | (242) | (2,049) |
Net Loss | (4,509) | (766) | (10,253) | (1,698) |
Preferred stock dividends - declared | 0 | (1,912) | 0 | (5,702) |
Preferred stock dividends - undeclared | (1,912) | 0 | (5,736) | 0 |
Net loss attributable to Regional Health Properties, Inc. common stockholders | $ (6,421) | $ (2,678) | $ (15,989) | $ (7,400) |
Net loss (income) per share of common stock attributable to Regional Health Properties, Inc. | ||||
Continuing operations, basic and diluted (in dollars per share) | $ (0.33) | $ (0.08) | $ (0.79) | $ (0.27) |
Discontinued operations, basic and diluted (in dollars per share) | 0.01 | (0.05) | (0.01) | (0.10) |
Net loss per share of common stock attributable to Regional Health Properties, Inc. | $ (0.32) | $ (0.13) | $ (0.80) | $ (0.37) |
Weighted average shares of common stock outstanding: | ||||
Basic and diluted (in shares) | 20,187 | 19,762 | 19,914 | 19,784 |
Management Fees | ||||
Revenues: | ||||
Management fees and other revenues | $ 235 | $ 229 | $ 703 | $ 688 |
Other Revenues | ||||
Revenues: | ||||
Management fees and other revenues | $ 49 | $ 133 | $ 148 | $ 393 |
CONSOLIDATED STATEMENT OF STOCK
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) - 9 months ended Sep. 30, 2018 - USD ($) shares in Thousands, $ in Thousands | Total | Shares of Common Stock | Shares of Preferred Stock | Common Stock and Additional Paid-in Capital | Preferred Stock | Accumulated Deficit |
Balance at Dec. 31, 2017 | $ 17,870 | $ 61,724 | $ 62,423 | $ (106,277) | ||
Balance (in shares) at Dec. 31, 2017 | 19,697 | 19,697 | ||||
Balance (in shares) at Dec. 31, 2017 | 2,812 | 2,812 | ||||
Increase (Decrease) in Stockholders' Equity | ||||||
Stock-based compensation | $ 126 | 126 | ||||
Issuance of restricted stock, net of forfeitures (in shares) | 490 | |||||
Net loss | (10,253) | (10,253) | ||||
Balance at Sep. 30, 2018 | $ 7,743 | $ 61,850 | $ 62,423 | $ (116,530) | ||
Balance (in shares) at Sep. 30, 2018 | 20,187 | 20,187 | ||||
Balance (in shares) at Sep. 30, 2018 | 2,812 | 2,812 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Cash flows from operating activities: | ||
Net Loss | $ (10,253) | $ (1,698) |
Loss from discontinued operations, net of tax | 242 | 2,049 |
(Loss) income from continuing operations | (10,011) | 351 |
Adjustments to reconcile net (loss) income from continuing operations to net cash provided by operating activities: | ||
Depreciation and amortization | 3,507 | 3,499 |
Settlement agreements in excess of cash paid | 300 | |
Stock-based compensation expense | 126 | 281 |
Rent expense in excess of cash paid | 301 | 440 |
Rent revenue in excess of cash received | (1,784) | (2,138) |
Amortization of deferred financing costs, debt discounts and premiums | 698 | 241 |
Loss on debt extinguishment | 3,955 | |
Bad debt expense | 3,934 | 455 |
Changes in operating assets and liabilities: | ||
Accounts receivable | (349) | 409 |
Prepaid expenses and other | 239 | 202 |
Other assets | 35 | (16) |
Accounts payable, and accrued expenses and other | 663 | 324 |
Other liabilities | 7 | 167 |
Net cash provided by operating activities - continuing operations | 1,321 | 4,515 |
Net cash used in operating activities - discontinued operations | (1,264) | (961) |
Net cash provided by operating activities | 57 | 3,554 |
Cash flows from investing activities: | ||
Change in net cash investments | (35) | |
Purchase of real estate, net | (1,375) | |
Purchase of property and equipment | (266) | (774) |
Net cash used in investing activities - continuing operations | (266) | (2,184) |
Net cash used in investing activities | (266) | (2,184) |
Cash flows from financing activities: | ||
Proceeds from debt issuance | 2,397 | |
Repayment on notes payable | (1,546) | (3,038) |
Repayment on bonds payable | (95) | (90) |
Repayment of convertible debt | (7,700) | |
Debt issuance costs | (95) | |
Proceeds from preferred stock issuances, net | 977 | |
Repurchase of common stock | (186) | |
Dividends paid on preferred stock | (5,702) | |
Net cash provided by (used in) financing activities - continuing operations | 661 | (15,739) |
Net cash used in financing activities - discontinued operations | (188) | (485) |
Net cash provided by (used in) financing activities | 473 | (16,224) |
Net change in cash and restricted cash | 264 | (14,854) |
Cash and restricted cash, beginning | 5,359 | 19,509 |
Cash and restricted cash, ending | 5,623 | 4,655 |
Supplemental disclosure of cash flow information: | ||
Interest paid | 3,775 | 2,840 |
Income taxes paid | 33 | 13 |
Supplemental disclosure of non-cash activities: | ||
Non-cash payments of long-term debt | (8,744) | |
Non-cash payments of convertible debt | (1,500) | |
Non-cash payments of professional liability settlements from financing | (2,371) | |
Non-cash debt issuance costs and prepayment penalties | (1,238) | |
Non-cash payments of professional liability settlements from prior insurer | (2,850) | |
Net payments through escrow | (16,703) | |
Non-cash proceeds from financing | 13,853 | |
Non-cash proceeds from prior insurer for professional liability settlements | 2,850 | |
Net proceeds through escrow | 16,703 | |
Non-cash proceeds from debt to purchase real estate | 4,125 | |
Non-cash deferred financing | 3,352 | |
Surrender of security deposit | 305 | 500 |
Non-cash proceeds from vendor-financed insurance | $ 198 | 198 |
Settlement agreements in excess of cash paid | 300 | |
Non-cash proceeds from financing of South Carolina Medicaid audit repayment | $ 385 |
Organization and Significant Ac
Organization and Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2018 | |
Accounting Policies [Abstract] | |
Organization and Significant Accounting Policies | NOTE 1. ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES Description of Business AdCare Health Systems, Inc. (“AdCare”) is the former parent of, and the predecessor issuer to, Regional Health Properties, Inc. (“Regional Health” and, together with its subsidiaries, the “Company” or “we”). On September 29, 2017, AdCare merged (the “Merger”) with and into Regional Health, a Georgia corporation and wholly owned subsidiary of AdCare formed for the purpose of the Merger, with Regional Health continuing as the surviving corporation in the Merger. The Company now has many of the characteristics of a real estate investment trust (“REIT”) and is focused on the ownership, acquisition and leasing of healthcare related properties. For a description of the Merger, see Part II, Item 8, Financial Statements and Supplemental Data , Summary of Significant Accounting Policies The Company is a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living. The Company’s business primarily consists of leasing and subleasing healthcare facilities to third-party tenants, which operate the facilities. The operators of the Company’s facilities provide a range of healthcare services, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for both long-term and short-stay patients and residents. As of September 30, 2018, the Company owned, leased, or managed for third parties 30 facilities, primarily in the Southeast United States. Of the 30 facilities, the Company: (i) leased 14 owned facilities and subleased 11 leased skilled nursing facilities to third-party tenants; (ii) leased two owned assisted living facilities to third-party tenants; and (iii) managed on behalf of third-party owners two skilled nursing facilities and one independent living facility (see Note 7 – Leases , – Leases The Company leases its currently-owned healthcare properties, and subleases its currently-leased healthcare properties, on a triple-net basis, meaning that the lessee (i.e., the third-party operator of the property) is obligated under the lease or sublease, as applicable, for all costs of operating the property, including insurance, taxes and facility maintenance, as well as the lease or sublease payments, as applicable. These leases are generally long-term in nature with renewal options and annual rent escalation clauses. When used in this Quarterly Report on Form 10-Q (this “Quarterly Report”), unless otherwise specifically stated or the context otherwise requires, the terms: • “Board” refers to the Board of Directors of AdCare with respect to the period prior to the Merger and to the Board of Directors of Regional Health with respect to the period after the Merger; • “common stock” refers to AdCare’s common stock with respect to the period prior to the Merger and to Regional Health’s common stock with respect to the period after the Merger; and • “Series A Preferred Stock” refers to AdCare’s 10.875% Series A Cumulative Redeemable Preferred Stock with respect to the period prior to the Merger and to Regional Health’s 10.875% Series A Cumulative Redeemable Preferred Stock with respect to the period after the Merger. Basis of Presentation The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations for the periods presented have been included. Operating results for the three and nine months ended September 30, 2018 and 2017 are not necessarily indicative of the results that may be expected for the fiscal year. The balance sheet at December 31, 2017 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. You should read the unaudited consolidated financial statements in this Quarterly Report together with the historical audited consolidated financial statements of the Company for the year ended December 31, 2017, included in the Annual Report. See Part II, Item 8, Financial Statements and Supplementary Data , Summary of Significant Accounting Policies Recently Adopted Standards. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Revenue Recognition and Allowances Triple-Net Leased Properties. The Company's triple-net leases provide for periodic and determinable increases in rent. The Company recognizes rental revenues under these leases on a straight-line basis over the applicable lease term when collectability is probable. Recognizing rental income on a straight-line basis generally results in recognized revenues during the first half of a lease term exceeding the cash amounts contractually due from our tenants, creating a straight-line rent receivable that is included in straight-line rent receivable on our consolidated balance sheets. In the event the Company cannot reasonably estimate the future collection of rent from one or more tenant(s) of the Company’s facilities, rental income for the affected facilities will be recognized only upon cash collection, and any accumulated straight-line rent receivable will be reversed in the period in which the Company deems rent collection no longer probable. Rental revenues for five facilities located in Ohio and one facility in North Carolina are recorded on a cash basis (for additional information with respect to such facilities, see Note 7 ). Allowances. The Company assesses the collectability of its rent receivables, including straight-line rent receivables and working capital loans to tenants. The Company bases its assessment of the collectability of rent receivables and working capital loans to tenants on several factors, including payment history, the financial strength of the tenant and any guarantors, the value of the underlying collateral, and current economic conditions. If the Company's evaluation of these factors indicates it is probable that the Company will be unable to receive the rent payments or payments on a working capital loan, then the Company provides a reserve against the recognized straight-line rent receivable asset or working capital loan for the portion that we estimate may not be recovered. If the Company changes its assumptions or estimates regarding the collectability of future rent payments required by a lease or required from a working capital loan to a tenant, then the Company may adjust its reserve to increase or reduce the rental revenue or interest revenue from working capital loans to tenants recognized in the period the Company makes such change in its assumptions or estimates, see Note 7 ). As of September 30, 2018 and December 31, 2017, the Company reserved for approximately $1.4 million and $2.6 million, respectively, of gross patient care related receivables arising from its legacy operations. Allowances for patient care receivables are estimated based on an aged bucket method as well as additional analyses of remaining balances incorporating different payor types. Any changes in patient care receivable allowances are recognized as a component of discontinued operations. All uncollected patient care receivables were fully reserved at September 30, 2018 and December 31, 2017. Accounts receivable, net, totaled $0.9 million at September 30, 2018 and $0.9 million at December 31, 2017. Extinguishment of Debt The Company recognizes extinguishment of debt when the criteria for a troubled debt restructure are not met and the change in Pre-paid expenses and other As of September 30, 2018 and December 31, 2017, the Company had $0.3 million and $0.3 million, respectively, in pre-paid expenses and other, primarily for directors’ and officers’ insurance and mortgage insurance premiums. Self-Insurance The Company has self-insured against professional and general liability claims since it discontinued its healthcare operations during 2014 and 2015 in connection with its transition from an owner and operator of healthcare properties to a healthcare property holding and leasing company (see Part II, Item 8, Financial Statements and Supplementary Data , – Commitments and Contingencies – Accrued Expenses and Other Other o p Other operating expenses decreased by approximately $0.2 million, or 50.7%, to $0.3 million for the three months ended September 30, 2018, compared with $0.5 million for the same period in 2017. The decrease is due to: (i) a $0.3 million settlement expense related to Mr. McBride, the Company’s former Chief Executive Officer and Chairman of the Board, in the prior year period; and (ii) $0.1 million investigation expense related to an internal investigation in the prior year period, offset by: (i) $0.1 million accrual for property taxes related to facilities whose rent payments are being recognized on a cash received basis; and (ii) approximately $0.1 million increase in contract services. Other expense decreased by $0.1 million, or 100.0%, for the three months ended September 30, 2018, compared with $0.1 million for the same period in 2017 and decreased by $0.4 million, or 97.4%, for the nine months ended September 30, 2018, compared with $0.4 million for the same period in 2017. The prior period charge was related to expenses for the Merger. Reclassifications Certain reclassifications have been made to the 2017 financial information to conform to the 2018 presentation with no effect on the Company's consolidated financial position or results of operations. These reclassifications did not affect total assets, total liabilities, or stockholders' equity. Reclassifications were made to the consolidated statements of operations for the three and nine months ended September 30, 2017 to conform the presentation of: (i) management fee revenues and its related expense, previously reported as general and administrative expense; and (ii) provision for doubtful accounts previously reported as Other operating expenses. Reclassifications were made to the consolidated statements of cash flows for the nine months ended September 30, 2017 to include restricted cash in cash and restricted cash at the beginning-of-period and end-of-period totals. Recently On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers Accounting Standards Codification ASC”) The Company has one contract (the “Management Contract”) to manage two skilled nursing facilities and one independent living facility for a third party, with payment for each month of service received in full on a monthly basis. Companies are permitted to adopt the standard using a retrospective transition method (i.e., restate all prior periods presented) or a cumulative effect method (i.e., recognize the cumulative effect of initially applying the guidance at the date of initial application with no restatement of prior periods). However, both methods allow companies to elect certain practical expedients on transition that will help to simplify how a company restates its contracts. The Company adopted the standard using the cumulative effect method. As a result of the adoption of this guidance, for the three and nine months ended September 30, 2017, the Company reclassified expenses related to the Management Contract from General and administrative expense to Cost of management fees on the consolidated statements of operations. In August 2016, the FASB issued ASU 2016-1 Classification of Certain Cash Receipts and Cash Payments ASU 2016-15 In November 2016, the FASB issued ASU 2016-18 Restricted Cash ASU 2016-18 Recent Significant Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02 Leases ASU 2018-11, Leases (Topic 842) Targeted Improvements, ASU 2016-02 ASU 2016-02 ASU 2018-11 See Part II, Item 8, Financial Statements and Supplementary Data , Summary of Significant Accounting Policies |
Earnings Per Share
Earnings Per Share | 9 Months Ended |
Sep. 30, 2018 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | NOTE 2. Basic earnings per share is computed by dividing net income or loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the respective period. Diluted earnings per share is similar to basic earnings per share except: (i) net income or loss is adjusted by the impact of the assumed conversion of convertible debt into shares of common stock; and (ii) the weighted-average number of shares of common stock outstanding includes potentially dilutive securities (such as options, warrants, non-vested common stock and additional shares of common stock issuable under convertible debt outstanding during the period) when such securities are not anti-dilutive. Potentially dilutive securities from options, warrants and unvested restricted shares are calculated in accordance with the treasury stock method, which assumes that proceeds from the exercise of all options and warrants with exercise prices exceeding the average market value are used to repurchase common stock at market value. The incremental shares remaining after the proceeds are exhausted represent the potentially dilutive effect of the securities. Potentially dilutive securities from convertible debt are calculated based on the assumed issuance at the beginning of the period, as well as any adjustment to income that would result from their assumed issuance. For the three and nine months ended September 30, 2018 and 2017, approximately 1.2 million and 2.4 million shares, respectively, of potentially dilutive securities were excluded from the diluted loss per share calculation because including them would have been anti-dilutive for such periods. The following tables provide a reconciliation of net income (loss) for continuing and discontinued operations and the number of shares of common stock used in the computation of both basic and diluted earnings per share: Three Months Ended September 30, Nine Months Ended September 30, (Amounts in 000’s, except per share data) 2018 2017 2018 2017 Numerator: (Loss) income from continuing operations $ (4,666 ) $ 266 $ (10,011 ) $ 351 Preferred stock dividends - declared — (1,912 ) — (5,702 ) Preferred stock dividends - undeclared (1) (1,912 ) — (5,736 ) — Basic and diluted loss from continuing operations (6,578 ) (1,646 ) (15,747 ) (5,351 ) Income (loss) from discontinued operations, net of tax 157 (1,032 ) (242 ) (2,049 ) Net loss attributable to Regional Health Properties, Inc. common stockholders $ (6,421 ) $ (2,678 ) $ (15,989 ) $ (7,400 ) Denominator: Basic - weighted average shares 20,187 19,762 19,914 19,784 Diluted - adjusted weighted average shares (2) 20,187 19,762 19,914 19,784 Basic and diluted loss per share: Loss from continuing operations attributable to Regional Health $ (0.33 ) $ (0.08 ) $ (0.79 ) $ (0.27 ) Income (loss) from discontinued operations 0.01 (0.05 ) (0.01 ) (0.10 ) Loss attributable to Regional Health Properties, Inc. common stockholders $ (0.32 ) $ (0.13 ) $ (0.80 ) $ (0.37 ) (1) The Board suspended dividend payments with respect to the Series A Preferred Stock for the fourth quarter 2017, the first, second and third quarter 2018. On June 8, 2018, the Board determined to continue suspension of the payment of the quarterly dividend indefinitely. (2) Securities outstanding that were excluded from the computation, because they would have been anti-dilutive were as follows: September 30, (Share amounts in 000’s) 2018 2017 Stock options 181 245 Warrants - employee 582 1,350 Warrants - non employee 437 437 Shares issuable upon conversion of convertible debt — 353 Total anti-dilutive securities 1,200 2,385 |
Liquidity
Liquidity | 9 Months Ended |
Sep. 30, 2018 | |
Liquidity [Abstract] | |
Liquidity | NOTE 3. LIQUIDITY The Company plans to undertake measures to grow its operations, streamline its cost infrastructure and otherwise increase liquidity by: (i) replacing certain tenants who are in default of their lease payment terms; (ii) increasing future lease revenue through acquisitions and investments in existing properties; (iii) modifying the terms of existing leases; (iv) refinancing or repaying debt classified as current and longer term debt to reduce interest costs and mandatory principal repayments; and (v) reducing general and administrative expenses. Management anticipates access to several sources of liquidity, including cash on hand, cash flows from operations (assuming that new tenants, for five of the Company’s facilities located in Ohio, are in place by December 31, 2018), and debt refinancing during the twelve months from the date of this filing. At September 30, 2018, the Company had $1.9 million in unrestricted cash. During the nine months ended September 30, 2018, the Company generated positive cash flow from continuing operations of $1.3 million and anticipates continued positive cash flow from operations in the future. On June 8, 2018, the Board indefinitely suspended dividend payments with respect to the Series A Preferred Stock. Such dividends are currently in arrears for the fourth quarter 2017 and the first, second and third quarter 2018 dividend periods. The Board plans to revisit the dividend payment policy with respect to the Series A Preferred Stock on an ongoing basis. The Board believes that the dividend suspension will provide the Company with additional funds to meet its ongoing liquidity needs. As of September 30, 2018, the Company had total current liabilities of $34.5 million and total current assets of $5.0 million, resulting in a working capital deficit of approximately $29.5 million. Included in current liabilities at September 30, 2018 is the $25.7 million current portion of the Company’s $80.9 million in indebtedness. The current portion of such indebtedness is comprised of approximately: (i) $19.3 million of long term-debt (including a $0.5 million “tail fee”) under the Pinecone Credit Facility (as defined below), net of $0.1 associated deferred financing costs, classified as current due to the Company’s short-term forbearance agreement pursuant to noncompliance with certain covenants under the Pinecone Credit Facility and the lender’s ability to exercise default-related rights and remedies, including the acceleration of the maturity of such debt (as discussed below in this note); (ii) $4.1 million of senior debt associated with one facility in Oklahoma as described below maturing in April 2019, which we intend to seek to refinance as described below; (iii) $1.4 million of mortgage indebtedness included in the Company’s senior guaranteed debt; and (iv) other mortgage indebtedness of approximately $0.9 million. The Company anticipates net principal repayments of approximately $2.4 million (excluding the potential acceleration of the $19.3 million debt under the Pinecone Credit Facility and the $4.1 million associated with one facility located in Oklahoma maturing in April 2019) during the next twelve-month period and approximately $0.8 million of payments on other non-routine debt. The Company intends to seek to refinance the Company’s credit facility with Housing & Healthcare Finance, LLC (the “Quail Creek Credit Facility”), which is secured by a first mortgage on the real property and improvements constituting the Nursing & Rehabilitation Center located in Oklahoma City, Oklahoma and currently has a maturity date of April 30, 2019. There is no assurance that the Company will be able to do so on terms that are favorable to the Company or at all. On February 15, 2018, (the “Closing Date”) the Company entered into a debt refinancing (“Pinecone Credit Facility”) with Pinecone Realty Partners II, LLC (“Pinecone”), with an aggregate principal amount of $16.25 million, which refinanced existing mortgage debt in an aggregate amount of $8.7 million on three skilled nursing properties known as Attalla, College Park and Northwest (the “Facilities”), – Notes Payable and Other Debt On May 10, 2018, Pinecone notified the Company in writing (the “Default Letter”) that the Company was in default under certain financial covenants of the loan documents evidencing the Pinecone Credit Facility (the “Pinecone Loan Documents”). On May 18, 2018, the Company and certain of its subsidiaries entered into a Forbearance Agreement with Pinecone with respect to the specified events of default set forth therein (the “Original Forbearance Agreement”), pursuant to which, among other things, additional fees in the amount of $0.4 million were added to the outstanding principal balance under the Pinecone Credit Facility. The forbearance period under the Original Forbearance Agreement terminated on July 6, 2018 because the Company did not satisfy conditions in the Original Forbearance Agreement that required the Company to enter into an agreement with Pinecone to support a transaction or series of transactions to remedy the defaults specified in the Default Letter and the Original Forbearance Agreement. On September 6, 2018, the Company and certain of its subsidiaries entered into a new Forbearance Agreement (the “New Forbearance Agreement”) with Pinecone pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the New Forbearance Agreement, to forbear for a specified period of time from exercising its default-related rights and remedies (including the acceleration of the outstanding loans and charging interest at the specified default rate) with respect to specified events of default (the “Specified Defaults”) under the Pinecone Loan Documents. The forbearance period under the New Forbearance Agreement is from September 6, 2018, the date on which certain conditions set forth in the New Forbearance Agreement were satisfied, to December 31, 2018, unless the forbearance period is earlier terminated as a result of specified termination events, including a default or event of default under the Pinecone Loan Documents (other than any Specified Defaults) or any failure by the Company or its subsidiaries to comply with the New Forbearance Agreement. Pursuant to the New Forbearance Agreement, the Company and Pinecone agreed to amend certain provisions of the Pinecone Loan Documents. Such amendments, among other things: (i) remove the restriction on prepaying the loans during the thirteen (13) month-period after the Closing Date; (ii) provide a thirty (30)-day cure period for certain events of default and a fifteen (15)-day cure period for certain failures to provide information or materials pursuant to the Pinecone Loan Documents; (iii) increase the finance fee payable on repayment or acceleration of the loans, depending on the time at which the loans are repaid ($0.25 million prior to December 31, 2018 and $0.5 million thereafter); and (iv) increase the outstanding principal balance owed by (a) approximately $0.7 million to reimburse Pinecone for its accrued and unpaid expenses and to pay outstanding interest payments for prior interest periods and (b) $1.5 million fee described as a non-refundable payment of additional interest. During the forbearance period under the New Forbearance Agreement, the interest rate will revert from the default rate of 18.5% per annum to the ongoing rate of 13.5% per annum. Upon the occurrence of an event of default (other than the Specified Defaults), or the expiration or termination of the forbearance period under the New Forbearance Agreement, Pinecone may declare the entire unpaid principal balance under the In addition, the equity interests in substantially all of Regional Health’s direct and indirect, wholly-owned subsidiaries (the “Pledged Subsidiaries”) have been pledged to Pinecone as part of the Collateral. The assets and operations of the Pledged Subsidiaries constitute substantially all of the Company’s assets and operations. Upon the occurrence of an event of default (other than the Specified Defaults) or the expiration or termination of the forbearance period under the New Forbearance Agreement, Pinecone may, in addition to its other rights and remedies, remove any or all of the managers of the Pledged Subsidiaries and appoint its own representatives as managers of such Pledged Subsidiaries. If Pinecone elects to appoint its own representatives as managers of the Pledged Subsidiaries, then such managers would control such subsidiaries and their assets and operations and could potentially restrict or prevent such subsidiaries from paying dividends or distributions to Regional Health. As a holding company with no significant operations, Regional Health relies primarily on dividends and distributions from the Pledged Subsidiaries to meet its obligations and pay dividends on its capital stock (when and as declared by the Board.) The Pinecone Loan Documents provide that Pinecone’s rights and remedies upon an event of default are cumulative, and that Pinecone may exercise (although it is not obligated to do so) all or any one or more of the rights and remedies available to it under the Pinecone Loan Documents or applicable law. The Company does not know which rights and remedies, if any, Pinecone may choose to exercise under the Pinecone Loan Documents upon the occurrence of an event of default (other than the Specified Defaults) or the expiration or termination of the forbearance period under the New Forbearance Agreement. If Pinecone elects to appoint its own representatives as managers of the Pledged Subsidiaries, to accelerate the indebtedness under the Pinecone Credit Facility, or to foreclose on significant assets of the Company (such as the Facilities and/or the equity interests in the Pledged Subsidiaries), then it will have a material adverse effect on the Company’s liquidity, cash flows, financial condition and results of operations, and the Company’s ability to continue operations will be materially jeopardized. The current forbearance period under the New Forbearance Agreement expires on December 31, 2018, unless earlier terminated upon the occurrence of specified termination events under the New Forbearance Agreement. As of such date, Pinecone will no longer be required to forbear from exercising its default-related rights and remedies with respect to the Specified Defaults and may exercise all of its rights and remedies with respect to the Pinecone loan Documents at that time. As of September 30, 2018, eight of the Company’s facilities were in arrears’ on their rent payments. Combined cash rental payments for all eight facilities total $0.4 million per month, or approximately 21% of our anticipated total monthly rental receipts. As of September 30, 2018 the facilities in Ohio owe in aggregate approximately $1.8 million and the Symmetry related facilities owe in aggregate approximately $0.6 million. Five of these facilities located in Ohio and leased to affiliates of Beacon Health Management, LLC (“Beacon”) and the Company has issued default notices to the operators of such facilities. Of the remaining three facilities in arrears on their rental payments, one such facility is located in North Carolina and two such facilities are located in South Carolina and all three of such facilities are leased to affiliates of Symmetry Healthcare Management, LLC (“Symmetry”) (for additional information with respect to such facilities, see Note 7 – Leases On September 20, 2018, the Company reached an agreement with Symmetry, pursuant to which Symmetry agreed to a payment plan for rent arrears and the Company agreed to an aggregate reduction of approximately $0.6 million in annualized rent with respect to the three facilities leased to Symmetry and waived approximately $0.2 million in rent that was in arrears with respect to such facilities, upon which Symmetry recommenced monthly rent payments with respect to such facilities of $0.1 million in the aggregate, starting with the September 1, 2018 amounts due. Management is currently in negotiations with the operators of the facilities located in Ohio to obtain payment of all unpaid rents and to implement plans to ensure the future payment of rent. Such plans may include replacing one or more of the current operators or negotiating a new agreement with one or more of the current operators to resume rent payments. If the Company agrees to additional or revised terms with any current operator, such terms may be less favorable to the Company than the terms provided in the current lease. Management believes that the Company will attain a resolution that allows for the resumption of rent at the remaining five facilities within a relatively short time frame. If the Company is unable to resume collection of rent with respect to the five facilities, it will hinder the Company’s ability to meet its obligations arising within one year of the date of issuance of these consolidated financial statements. On August 28, 2018, the Company received a deficiency letter (the “Letter”) from NYSE American LLC (“NYSE American” or the “Exchange”) stating that the Company is not in compliance with the continued listing standards as set forth in Section 1003(f)(v) of the NYSE American Company Guide (the “Company Guide”). Specifically, the Letter informed the Company that the Exchange has determined that shares of the Company’s securities have been selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the Company Guide, the Company’s continued listing is predicated on the Company effecting a reverse stock split of the common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which the Exchange determined to be no later than February 27, 2019. As a result of such noncompliance, the Company has become subject to the procedures and requirements of Section 1009 of the Company Guide. The Company intends to regain compliance with the continued listing standards set forth in the Company Guide by undertaking a measure or measures that are in the best interests of the Company and its shareholders. In connection with such efforts, the Company is submitting for approval at the Company’s 2018 annual meeting of shareholders a proposal to amend the Company’s Amended and Restated Articles of Incorporation to effect a reverse stock split of the common stock at a ratio of between one-for-six and one-for-twelve, as determined by the Board in its sole discretion. The common stock and Series A Preferred Stock will continue to be listed on the NYSE American while the Company seeks to regain compliance with the continued listing standard noted, subject to the Company’s compliance with other continued listing requirements. If the Company fails to demonstrate a sustained price improvement or effect a reverse stock split of its common stock by February 27, 2019, then the Exchange may commence delisting procedures. The Company does not expect the Letter to affect the Company’s business operations, or its reporting obligations under the Securities and Exchange Commission regulations and rules, however management’s ability to raise additional capital through the issuance of equity securities and the terms upon which we are able to raise such capital may be adversely affected if we are unable to maintain the listing of the common stock and the Series A Preferred Stock on the NYSE American. Under the accounting guidance related to the presentation of financial statements, the Company is required to evaluate, on a quarterly basis, whether or not the entity’s current financial condition, including its sources of liquidity at the date that the consolidated financial statements are issued, will enable the entity to meet its obligations as they come due arising within one year of the date of the issuance of the Company’s consolidated financial statements and to make a determination as to whether or not it is probable, under the application of this accounting guidance, that the entity will be able to continue as a going concern. The Company’s consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. In applying applicable accounting guidance, management considered the Company’s current financial condition and liquidity sources, including current funds available, forecasted future cash flows, the Company’s obligations due over the next twelve months, the likelihood that the Company will be able to comply with the requirements in the Pinecone Loan Documents, including the New Forbearance Agreement, and Pinecone’s remedies in the event of non-compliance, as well as the Company’s recurring business operating expenses. There is no assurance that the Company will be able to comply with all of the requirements under the Pinecone Loan Documents, including the New Forbearance Agreement. Such compliance depends, in part, on the Company’s ability to work with outside parties, which is not within the Company’s exclusive control. If the Company is unable to comply with all the requirements under the Pinecone Loan Documents, including the New Forbearance Agreement, and Pinecone were to accelerate all obligations under the Pinecone Loan Documents or otherwise exercise its default-related rights or foreclose on the Collateral, then it would have a material adverse consequence on the Company’s ability to meet its obligations arising within one year of the date of issuance of these consolidated financial statements. The Company plans to continue to undertake measures to refinance certain loans, including the Pinecone Credit Facility, and to streamline its cost infrastructure. There is no assurance however, that these efforts will be successful. Due to the inherent risks, unknown results, and significant uncertainties associated with each of these matters along with the direct correlation between these matters and the Company’s ability to satisfy the financial obligations that may arise over the applicable one-year period, the Company is unable to conclude that it is probable that the Company will be able to meet its obligations arising within one year of the date of issuance of these consolidated financial statements within the parameters set forth in the accounting guidance. |
Cash and Restricted Cash
Cash and Restricted Cash | 9 Months Ended |
Sep. 30, 2018 | |
Restricted Cash And Investments [Abstract] | |
Cash and Cash Equivalents Disclosure | NOTE 4. CASH AND RESTRICTED CASH The following presents the Company's cash and restricted cash: (Amounts in 000’s) September 30, 2018 December 31, 2017 Cash $ 1,884 $ 1,818 Restricted cash: Cash collateral 44 63 Replacement reserves 297 260 Escrow deposits 768 637 Total current portion 1,109 960 Restricted cash for debt obligations 365 405 HUD and other replacement reserves 2,265 2,176 Total noncurrent portion 2,630 2,581 Total restricted cash 3,739 3,541 Total cash and restricted cash $ 5,623 $ 5,359 Cash collateral —In securing mortgage financing from certain lending institutions, the Company and certain of its wholly-owned subsidiaries are required to deposit cash to be held as collateral in accordance with the terms of such loan agreements. Replacement reserves —Cash reserves set aside for non-critical building repairs for completion within the next 12 months, pursuant to loan agreements. Escrow deposits —In connection with financing secured through the Company’s lenders, several wholly-owned subsidiaries of the Company are required to make monthly escrow deposits for taxes and insurance. Restricted cash for other debt obligations —In compliance with certain financing and insurance agreements, the Company and certain wholly-owned subsidiaries of the Company are required to deposit cash held as collateral by the lender or in escrow with certain designated financial institutions. HUD and other replacement reserves —The regulatory agreements entered into in connection with the financing secured through the U.S. Department of Housing and Urban Development (“HUD”) require monthly escrow deposits for replacement and improvement of the HUD project assets. |
Property and Equipment
Property and Equipment | 9 Months Ended |
Sep. 30, 2018 | |
Property Plant And Equipment [Abstract] | |
Property and Equipment | NOTE 5. PROPERTY AND EQUIPMENT The following table sets forth the Company’s property and equipment: (Amounts in 000’s) Estimated Useful Lives (Years) September 30, 2018 December 31, 2017 Buildings and improvements 5-40 $ 89,624 $ 89,665 Equipment and computer related 2-10 9,634 10,893 Land — 4,137 4,248 Construction in process — 231 49 103,626 104,855 Less: accumulated depreciation and amortization (25,052 ) (23,642 ) Property and equipment, net $ 78,574 $ 81,213 The following table summarizes total depreciation and amortization expense for the three and nine months ended September 30, 2018 and 2017: Three Months Ended September 30, Nine Months Ended September 30, (Amounts in 000’s) 2018 2017 2018 2017 Depreciation $ 788 $ 857 $ 2,394 $ 2,486 Amortization 338 336 1,113 1,013 Total depreciation and amortization expense $ 1,126 $ 1,193 $ 3,507 $ 3,499 |
Intangible Assets and Goodwill
Intangible Assets and Goodwill | 9 Months Ended |
Sep. 30, 2018 | |
Goodwill And Intangible Assets Disclosure [Abstract] | |
Intangible Assets and Goodwill | NOTE 6. INTANGIBLE ASSETS AND GOODWILL Intangible assets consist of the following: (Amounts in 000’s) Bed licenses (included in property and equipment) (a) Bed Licenses - Separable Lease Rights Total Balances, December 31, 2017 Gross $ 22,811 $ 2,471 $ 7,181 $ 32,463 Accumulated amortization (4,166 ) — (4,994 ) (9,160 ) Net carrying amount $ 18,645 $ 2,471 $ 2,187 $ 23,303 Amortization expense (512 ) — (601 ) (1,113 ) Balances, September 30, 2018 Gross 22,811 2,471 7,181 32,463 Accumulated amortization (4,678 ) — (5,595 ) (10,273 ) Net carrying amount $ 18,133 $ 2,471 $ 1,586 $ 22,190 (a) Non-separable bed licenses are included in property and equipment as is the related accumulated amortization expense (see Note 5 – Property and Equipment The following table summarizes amortization expense for the three and nine months ended September 30, 2018 and 2017: Three Months Ended September 30, Nine Months Ended September 30, (Amounts in 000’s) 2018 2017 2018 2017 Bed licenses $ 171 $ 169 $ 512 $ 512 Lease rights 167 167 601 501 Total amortization expense $ 338 $ 336 $ 1,113 $ 1,013 Expected amortization expense for all definite-lived intangibles for each of the years ended December 31 is as follows: (Amounts in 000’s) Bed Licenses Lease Rights 2018 (a) $ 171 $ 166 2019 683 667 2020 683 482 2021 683 203 2022 683 68 Thereafter 15,230 - Total expected amortization expense $ 18,133 $ 1,586 (a) Estimated amortization expense for the year ending December 31, 2018, includes only amortization to be recorded after September 30, 2018. The following table summarizes the carrying amount of goodwill: (Amounts in 000’s) September 30, 2018 December 31, 2017 Goodwill $ 2,945 $ 2,945 Accumulated impairment losses (840 ) (840 ) Net carrying amount $ 2,105 $ 2,105 The Company does not amortize indefinite-lived intangibles, which consist of separable bed licenses and goodwill. |
Leases
Leases | 9 Months Ended |
Sep. 30, 2018 | |
Leases [Abstract] | |
Leases | NOTE 7. LEASES Operating Leases The Company leases eleven skilled nursing facilities from unaffiliated owners under non-cancelable leases, all of which have rent escalation clauses and provisions requiring payment of real estate taxes, insurance and maintenance costs by the lessee. Each of the skilled nursing facilities that are leased by the Company are subleased to and operated by third-party tenants. The Company also leases certain office space located in Suwanee, Georgia and Atlanta, Georgia. The Atlanta office space is subleased to a third-party tenant. As of September 30, 2018, the Company is in compliance with all operating lease financial covenants, except with respect to the leases for two facilities located in Georgia (the “Omega Facilities). Pursuant to the leases for the Omega Facilities, the Company is required to maintain a minimum tangible net worth of $5.0 million As of the date of filing, the Company’s tangible net worth is approximately $2.7 million, and the Company has not obtained a waiver with respect to the applicable financial covenant. The Company’s annual cash inflow from the Omega Facilities is approximately $2.2 million, with associated rent expense outflow being approximately $2.0 million, such leases expire in 2025. Future Minimum Lease Payments Future minimum lease payments for each of the next five years ending December 31, are as follows: (Amounts in 000’s) 2018 (a) $ 2,118 2019 8,526 2020 8,677 2021 8,830 2022 9,026 Thereafter 37,430 Total $ 74,607 (a) Estimated minimum lease payments for the year ending December 31, 2018 include only payments to be paid after September 30, 2018. Leased and Subleased Facilities to Third-Party Operators The Company leases or subleases 27 facilities (16 owned by the Company and 11 leased to the Company) to third-party tenants on a triple net basis, meaning that the lessee (i.e., the third-party tenant of the property) is obligated under the lease or sublease, as applicable, for all costs of operating the property, including insurance, taxes and facility maintenance, as well as the lease or sublease payments, as applicable. Arkansas Leases and Facilities . Until February 3, 2016, the Company subleased nine facilities located in Arkansas (the “Arkansas Facilities”) to affiliates of Aria Health Group, LLC (“Aria”) pursuant to separate sublease agreements (the “Aria Subleases”). Effective February 3, 2016, the Company terminated each Aria Sublease due to the applicable Aria affiliate’s failure to pay rent pursuant to the terms of such sublease. From April 1, 2016 to October 6, 2016, the Company leased the Arkansas Facilities to Skyline Healthcare LLC (“Skyline”), pursuant to a Master Lease Agreement, dated February 5, 2016 (the “Skyline Lease”). The term of the Skyline Lease commenced on April 1, 2016. In connection with the Skyline Lease, the Company entered into an Option Agreement, dated February 5, 2016, with Joseph Schwartz, the manager of Skyline, pursuant to which Mr. Schwartz, or an entity designated by Mr. Schwartz (the “Purchaser”), had an exclusive and irrevocable option to purchase the Arkansas Facilities at a purchase price of $55.0 million, consisting of cash consideration in the amount of $52.0 million and a promissory note with a principal amount of $3.0 million and a maturity date of March 31, 2022 (the “Skyline Note”). The Company completed the sale of the Arkansas Facilities to the Purchaser on October 6, 2016. The Skyline Note is guaranteed by Joseph Schwartz and Roselyn Schwartz (collectively, the “Guarantors”), pursuant to a Guaranty Agreement, dated September 30, 2016 (the “Guaranty”), executed by the Guarantors in favor of the Company (see Part II, Item 8, Financial Statements and Supplementary Data Note 10 included in the Annual Report). In connection with the closing of the sale of the Arkansas Facilities, the Company entered into a Subordination and Standstill Agreement, dated September 26, 2016 (the “Subordination Agreement”), with the Canadian Imperial Bank of Commerce (formerly the PrivateBank and Trust Company), as agent for the lenders specified therein (collectively, the “Lenders”). Pursuant to the Subordination Agreement, the Company agreed to subordinate its claims and rights to receive payment under the Skyline Note or any document which may evidence or secure the indebtedness evidenced by such note, other than the Guaranty (collectively, the “Subordinated Debt”), to the claims and rights of the Lenders to receive payment under certain revolving loans, with an initial aggregate principal amount of $6.0 million, and certain term loans, with an aggregate principal amount of $45.6 million (collectively, the “Loans”), each extended by certain of the Lenders to affiliates of Skyline (collectively, the “Skyline Borrowers”). Pursuant to the Subordination Agreement, the Company may not accept payment of the Subordinated Debt, or take any action to collect such payment, if: (i) the Company has received notice from the Lenders that the Skyline Borrowers have failed to meet a specified financial covenant with respect to the Loans; or (ii) a default has occurred or is continuing with respect to the Loans. Pursuant to the Guaranty, the Guarantors have agreed to pay the outstanding principal amount of the Skyline Note, together with all accrued and unpaid interest: (x) on the date on which the Skyline Borrowers or an affiliate thereof repays or refinances any of the Loans; (y) on the date on which the Skyline Borrowers or its affiliates sells any of the Arkansas Facilities which the Skyline Borrowers or its affiliates purchased with proceeds from the Loans; or (z) upon written notice from the Company to the Guarantors any time on or after the two year anniversary of the Skyline Note. As of the date of filing, the Company has not received written notice from the Lenders regarding conditions prohibiting repayment of the Skyline Note. On April 24, 2018, Skyline entered into a management contract with a third party to manage the Arkansas Facilities. On October 12, 2018, the Company accepted a payment of approximately $1.0 million from such third party in full satisfaction of the Skyline Note, which represents a discount from the full amount of $3.0 million outstanding thereunder. In connection with such payment, the Company agreed to release the Guarantors from their obligations under the Guaranty. Beacon. On August 1, 2015, the Company entered into a lease inducement fee agreement with certain affiliates (collectively, the "Beacon Affiliates") of Beacon, pursuant to which the Company paid a fee of $0.6 million as a lease inducement for certain Beacon Affiliates to enter into sublease agreements and to commence such subleases and transfer operations thereunder (the “Beacon Lease Inducement”). As of September 30, 2018, the balance of the Beacon Lease Inducement was approximately $0.5 million. On April 24, 2018, five Beacon affiliates (the “Ohio Beacon Affiliates”) informed the Company in writing that they would no longer be operating five (four owned and one leased by the Company) of the Company’s facilities located in Ohio (the “Ohio Beacon Facilities”) and that they would surrender operation of such facilities to the Company on June 30, 2018. As of the date of filing, the Ohio Beacon Affiliates have not surrendered possession of the Ohio Beacon Facilities and are nine months in arrears on rental payments. The Company intends to enforce its rights under the applicable sublease agreements for the Ohio Beacon Facilities and pursue all remedies available to it under such sublease agreements and applicable law. There is no assurance that the Company will be able to obtain payment of all unpaid rents under the leases for the Ohio Beacon Facilities. The Company is recognizing revenue on a cash basis with respect to the Ohio Beacon Facilities. During the first quarter of 2018, the Company expensed approximately $0.7 million straight-line rent asset, recorded an allowance of $0.5 million against the Beacon Lease Inducement and recorded approximately $0.3 million allowance for other receivables. The Company is in negotiations with suitably qualified replacement operators, who are undergoing the HUD approval process, for such facilities. The annualized 2018 cash rent under the lease agreements for the Ohio Beacon Facilities is shown below: Initial Lease Term 2018 Cash 2018 Cash Annual Rent Annual Rent Facility Name Operating Beds/Units Structure Commencement Date Expiration Date (Amounts in 000’s) % of Total Expected Ohio Covington Care 94 Leased 8/1/2015 4/30/2025 $ 818 3.7 % Eaglewood ALF 80 Owned 8/1/2015 7/31/2025 764 3.4 % Eaglewood Care Center 99 Owned 8/1/2015 7/31/2025 764 3.4 % H&C of Greenfield 50 Owned 8/1/2015 7/31/2025 382 1.7 % The Pavilion Care Center 50 Owned 8/1/2015 7/31/2025 382 1.7 % Total 373 $ 3,110 13.9 % Symmetry. Affiliates of Symmetry (the “Symmetry Tenants”) lease the following facilities from the Company, pursuant to separate lease agreements which expire in 2030 (the “Symmetry Leases”): (i) the Company’s 106 bed, skilled nursing facility located in Sylvia, North Carolina (the “Mountain Trace Facility”); (ii) the Company’s 96-bed, skilled nursing facility located in Sumter, South Carolina (the “Sumter Facility”); and (iii) the Company’s 84-bed, skilled nursing facility located in Georgetown, South Carolina (the “Georgetown Facility”). On June 27, 2018, the Company notified Blue Ridge of Sumter, LLC, the tenant with respect to the Sumter Facility (the “Sumter Tenant”), and Blue Ridge on the Mountain, LLC, the tenant with respect to the Mountain Trace Facility (the “Mountain Trace Tenant”), that continued breach of the payment terms of the applicable Symmetry Lease would constitute an event of default. The Symmetry Tenants had alleged that the Company was in material breach of each of the Symmetry Leases with regard to deferred maintenance and were withholding rental payments on the basis of such allegations. The Mountain Trace Tenant has not paid approximately $0.2 million in rent owned for April through August 2018, the Sumter Tenant has not paid approximately $0.3 million in rent owed for May through August 2018, and Blue Ridge in Georgetown, LLC, the tenant with respect to the Georgetown Facility (the “Georgetown Tenant”), has not paid $0.05 million in rent owed for July and August 2018. On September 20, 2018, the Company reached an agreement with the Symmetry Tenants with respect to the Symmetry Leases, pursuant to which the Symmetry Tenants agreed to a payment plan for the rent arrears and the Company agreed to a reduction in annualized rent of approximately $0.6 million (the “Rent Concession”) and waived approximately $0.2 million in rent arrears, upon which the Symmetry Tenants recommenced monthly rent payments of $0.1 million starting with the September 1, 2018 amounts due under the Symmetry Leases. The Company intends to enforce its rights under the lease agreement for the Mountain Trace Facility and pursue all remedies available to it under such lease agreement and applicable law. The Company is currently in negotiations with a suitably qualified replacement operator to take possession of the Mountain Trace Facility on December 1, 2018. There is no assurance that the Company will be able to execute a new lease with respect to the Mountain Trace Facility on substantially equivalent terms to the current lease agreement or at all or that, if a new lease is executed, the new tenant will be able to take possession of the Mountain Trace Facility on December 1, 2018. Consequently, the Company is recognizing revenue on a cash basis with respect to the Mountain Trace Facility and has expensed approximately $0.5 million of straight-line rent asset for the nine month period ended September 30, 2018. There is no assurance that the Company will be able to obtain payment of all unpaid rents and the collection of approximately $1.3 million (of asset balances shown in the table below) could be at risk. Balances, net of allowances as of September 30, 2018 and annualized cash rent under the lease agreements for the Symmetry affiliated facilities is shown below: (Amounts in 000’s) Facility Name Revenue Recognition Straight- Line Rent Asset Other Receivables 2018 Original Cash Annual Rent** % of Total Original Expected 2018 Cash Annual Rent** Annualized Rent Concession Granted* North Carolina Mountain Trace Cash basis $ — $ — $ 742 3.3 % $ 382 South Carolina Sumter Straight-line 537 409 836 3.8 % 236 Georgetown Straight-line 216 107 338 1.5 % 26 $ 753 $ 516 $ 1,916 8.6 % $ 644 *Effective September 1, 2018. ** Excludes concession granted Peach Health. On June 18, 2016, the Company entered into a master sublease agreement, as amended on March 30, 2018, (the “Peach Health Sublease”) with affiliates (collectively, “Peach Health Sublessee”) of Peach Health Group, LLC (“Peach Health”), providing that Peach Health Sublessee would take possession of and operate three facilities located in Georgia (the “Peach Facilities”) as subtenant. The Peach Facilities are comprised of: (i) an 85-bed skilled nursing facility located in Tybee Island, Georgia (the “Oceanside Facility”); (ii) a 50-bed skilled nursing facility located in Tybee Island, Georgia (the “Savannah Beach Facility”); and (iii) a 131-bed skilled nursing facility located in Jeffersonville, Georgia (the “Jeffersonville Facility”). In connection with the Peach Health Sublease, the Company extended a line of credit to Peach Health Sublessee for up to $1.0 million for operations at the Peach Facilities (the “Peach Line”), with an initial interest rate of 13.5% per annum, which increases by 1% per annum. The Peach Line had a maturity date one year from the date of the first disbursement and is secured by a first priority security interest in Peach Health Sublessee’s assets and accounts receivable. On April 6, 2017, the Company modified certain terms of the Peach Line in connection with Peach Health Sublessee securing a $2.5 million revolving working capital loan from a third party lender (the “Peach Working Capital Facility”), subsequently capped at $1.75 million, which matures April 5, 2020. At September 30, 2018, there was approximately $1.0 million outstanding on the Peach Line. Future minimum lease receivables from the Company’s facilities leased and subleased to third party tenants for each of the next five years ending December 31, are as follows: (Amounts in 000's) (b) 2018 (a) $ 4,660 2019 18,610 2020 19,040 2021 19,515 2022 20,002 Thereafter 94,216 Total $ 176,043 (a) Estimated minimum lease payments for the year ending December 31, 2018 include only payments to be paid after September 30, 2018. (b) Excludes amounts for the Ohio Beacon Facilities and Mountain Trace Tenant, and updated to reflect Symmetry Rent Concession. For further details regarding the Company’s leased and subleased facilities to third-party operators, see Part II, Item 8, Financial Statements and Supplementary Data, Note 7 - Leases – Acquisitions and Dispositions |
Accrued Expenses and Other
Accrued Expenses and Other | 9 Months Ended |
Sep. 30, 2018 | |
Payables And Accruals [Abstract] | |
Accrued Expenses and Other | NOTE 8. ACCRUED EXPENSES AND OTHER Accrued expenses and other consist of the following: (Amounts in 000’s) September 30, 2018 December 31, 2017 Accrued employee benefits and payroll-related $ 309 $ 290 Real estate and other taxes 704 423 Self-insured reserve (1) 1,832 5,077 Accrued interest 401 260 Other accrued expenses 974 972 Total accrued expenses and other $ 4,220 $ 7,022 (1) The Company self-insures against professional and general liability claims and uses a third party administrator and outside counsel to manage and defend the claims. Additionally, for the year ended December 31, 2017, $0.2 million was accrued in “Other liabilities” in the Company’s consolidated balance sheets for amounts due in excess of twelve months, (see Note 13 - Commitments and Contingencies) |
Notes Payable and Other Debt
Notes Payable and Other Debt | 9 Months Ended |
Sep. 30, 2018 | |
Debt Disclosure [Abstract] | |
Notes Payable and Other Debt | NOTE 9. NOTES PAYABLE AND OTHER DEBT See Part II, Item 8, Financial Statements and Supplementary Data, – Notes Payable and Other Debt Notes payable and other debt consists of the following: (Amounts in 000’s) September 30, 2018 December 31, 2017 Senior debt—guaranteed by HUD $ 33,066 $ 33,685 Senior debt—guaranteed by USDA (a) 13,831 20,320 Senior debt—guaranteed by SBA (b) 673 2,210 Senior debt—bonds 6,960 7,055 Senior debt—other mortgage indebtedness 27,398 9,486 Other debt 812 1,050 Convertible debt — 1,500 Subtotal 82,740 75,306 Deferred financing costs (1,665 ) (2,027 ) Unamortized discount on bonds (167 ) (177 ) Total debt 80,908 73,102 Less: current portion of debt 25,744 8,090 Notes payable and other debt, net of current portion $ 55,164 $ 65,012 (a) (b) The following is a detailed listing of the debt facilities that comprise each of the above categories: (Amounts in 000’s) Facility Lender Maturity Interest Rate (a) September 30, 2018 December 31, 2017 Senior debt - guaranteed by HUD (b) The Pavilion Care Center Red Mortgage 12/01/2027 Fixed 4.16 % $ 1,247 $ 1,329 Hearth and Care of Greenfield Red Mortgage 08/01/2038 Fixed 4.20 % 2,078 2,127 Woodland Manor Midland State Bank 10/01/2044 Fixed 3.75 % 5,246 5,334 Glenvue Midland State Bank 10/01/2044 Fixed 3.75 % 8,145 8,283 Autumn Breeze KeyBank 01/01/2045 Fixed 3.65 % 7,081 7,199 Georgetown Midland State Bank 10/01/2046 Fixed 2.98 % 3,584 3,644 Sumter Valley KeyBank 01/01/2047 Fixed 3.70 % 5,685 5,769 Total $ 33,066 $ 33,685 Senior debt - guaranteed by USDA (c) Attalla (e) Metro City 09/30/2035 Prime + 1.50% 5.50 % $ — $ 6,169 Coosa Metro City 09/30/2035 Prime + 1.50% 6.75 % 5,431 5,562 Mountain Trace Community B&T 01/24/2036 Prime + 1.75% 7.00 % 4,166 4,260 Southland Bank of Atlanta 07/27/2036 Prime + 1.50% 6.75 % 4,234 4,329 Total $ 13,831 $ 20,320 Senior debt - guaranteed by SBA (d) College Park (e) CDC 10/01/2031 Fixed 2.81 % $ — $ 1,523 Southland Bank of Atlanta 07/27/2036 Prime + 2.25% 7.50 % 673 687 Total $ 673 $ 2,210 (a) (b) (c) (d) (e) (Amounts in 000’s) Facility Lender Maturity Interest Rate (a) September 30, 2018 December 31, 2017 Senior debt - bonds Eaglewood Bonds Series A City of Springfield, Ohio 05/01/2042 Fixed 7.65 % $ 6,610 $ 6,610 Eaglewood Bonds Series B City of Springfield, Ohio 05/01/2021 Fixed 8.50 % 350 445 Total $ 6,960 $ 7,055 (a) (Amounts in 000’s) Facility Lender Maturity Interest Rate (a) September 30, 2018 December 31, 2017 Senior debt - other mortgage indebtedness Quail Creek (c) Congressional Bank 04/30/2019 LIBOR + 4.75% 5.75 % $ 4,136 $ 4,314 Northwest (d) First Commercial 07/31/2020 Prime 5.00 % — 1,122 Meadowood Exchange Bank of Alabama 05/01/2022 Fixed 4.50 % 3,951 4,050 College Park Pinecone (b) 08/15/2020 Fixed 13.50 % 2,727 — Northwest Pinecone (b) 08/15/2020 Fixed 13.50 % 2,685 — Attalla Pinecone (b) 08/15/2020 Fixed 13.50 % 8,705 — Adcare Property Holdings Pinecone (b) 08/15/2020 Fixed 13.50 % 5,194 — Total $ 27,398 $ 9,486 (a) (b) On February 15, 2018, the Company entered into the Pinecone Credit Facility with Pinecone. On September 6, 2018, the Company entered into the New Forbearance Agreement, which provided for certain amendments to the Pinecone Credit Facility (for further information see, “Pinecone Credit Facility” below in this Note). (c) On April 30, 2018, the Company extended the maturity date of the Quail Creek Credit Facility to April 30, 2019. (d) On February 15, 2018, the Company repaid this loan with proceeds from the Pinecone Credit Facility. (Amounts in 000’s) Lender Maturity Interest Rate September 30, 2018 December 31, 2017 Other debt First Insurance Funding 03/01/2019 Fixed 4.24 % $ 81 $ 20 Key Bank 08/02/2019 Fixed 0.00 % 495 495 McBride Note (a) 09/30/2019 Fixed 4.00 % 153 264 Pharmacy Care of Arkansas 02/08/2018 Fixed 2.00 % — 42 South Carolina Department of Health & Human Services (b) 02/24/2019 Fixed 5.75 % 83 229 Total $ 812 $ 1,050 (a) (b) (Amounts in 000’s) Facility Maturity Interest Rate September 30, 2018 December 31, 2017 Convertible debt Issued July 2012 (a) 04/30/2018 Fixed 14.00 % $ — $ 1,500 Total $ — $ 1,500 (a) On February 15, 2018, the Company repaid the outstanding principal balance to Cantone Asset Management, LLC, together with accrued interest thereon, with proceeds from the Pinecone Credit Facility. Pinecone Credit Facility On February 15, 2018, the Company entered into the Pinecone Credit Facility with Pinecone. The Company borrowed an aggregate principal amount of $16.25 million. The Pinecone Credit Facility refinanced existing mortgage debt in an aggregate amount of $8.7 million with respect to the Facilities. On May 18, 2018, the Company and Pinecone modified the debt and on September 6, 2018, the Company and Pinecone substantially changed the terms of the Loan to complete an exchange of debt and accordingly recorded a $3.5 million loss on extinguishment on the statement of operations for the period. The maturity date of the Pinecone Credit Facility is August 15, 2020 and it originally bore interest at a fixed rate equal to 10% per annum for the first three months after the Closing Date and at a fixed rate equal to 12.5% per annum thereafter, subject to adjustment upon an event of default and specified regulatory events. The Pinecone Credit Facility is secured by, among other things, first priority liens on the Facilities and all tangible and intangible assets of the borrowers owning the Facilities, including all rent payments received from the operators thereof. Accrued and unpaid interest on the outstanding principal amount of the Pinecone Credit Facility is payable in consecutive monthly installments. Unless accelerated by Pinecone, the entire unpaid principal amount of the Pinecone Credit Facility is due on the maturity date, together with all accrued and unpaid interest and a finance fee equal to 3% of the original principal amount. The Pinecone Credit Facility is subject to customary operating and financial covenants and regulatory conditions for each of the Facilities, which could result in additional monthly interest charges during any non-compliance and cure period. The Pinecone Credit Facility is prepayable in full beginning on the date that is thirteen months after the Closing Date, subject to the payment of a specified finance fee and, with respect to any prepayment made between March 15, 2019 and September 15, 2019, a prepayment premium equal to 1% of the principal amount being repaid. A specified early termination fee is payable in the event any amount is prepaid (in whole or in part) or is accelerated on or before the first anniversary of the Closing Date. The Pinecone Credit Facility and the related documentation provide for customary events of default. Upon the occurrence of certain events of default, Pinecone can declare: (i) the entire unpaid principal balance under the Pinecone Credit Facility, together with all accrued interest and other amounts payable, immediately due and payable; (ii) increase the interest rate to 18.5%; and (iii) foreclose on the Collateral. On May 10, 2018, management was notified by Pinecone that the certain events of default under the Pinecone Credit Facility had occurred and were continuing. On May 18, 2018, the Company and Pinecone entered into the Original Forbearance Agreement, pursuant to which Pinecone agreed, subject to terms and conditions set forth in the Original Forbearance Agreement, to forbear from exercising its default-related rights and remedies with respect to specified events of default under the Pinecone Credit Facility during the forbearance period provided for therein. The Original Forbearance Agreement outlined a plan of correction whereby the Company could regain compliance under the Pinecone Credit Facility . Requirements set forth in the included, among other things, (i) eliminate the Company’s obligation to complete certain lease assignments to suitably qualified replacement operators; (ii) require the payment of a specified “break-up fee” upon certain events, including prepayment of the Pinecone Credit Facility or a change of control; (iii) increase the ongoing interest rate from 12.5% per annum to The forbearance period under the Original Forbearance Agreement terminated on July 6, 2018 because the Company did not satisfy the condition set forth in the Original Forbearance Agreement requiring the Company to enter into an agreement with Pinecone to support a transaction or series of transactions to remedy the defaults specified in the Original Forbearance Agreement. Accordingly, as of such date, Pinecone was no longer required to forbear from exercising its default-related rights and remedies with respect to the specified defaults and could have exercised all of its rights and remedies under the Pinecone Credit Facility (including the application of an additional 5% interest on the outstanding loans under the Pinecone Credit Facility, the acceleration of such outstanding loans or foreclose on the Collateral). On July 18, 2018, the Company received a letter from Pinecone stating that, as a result of the termination of the forbearance period under the Original Forbearance Agreement, Pinecone could accelerate its outstanding loans under the Pinecone Credit Facility and the Company was obligated to pay interest on such loans at the default interest rate of 18.50% per annum. On September 6, 2018, the Company and certain of its subsidiaries entered into the New Forbearance Agreement with Pinecone pursuant to which Pinecone agreed, subject to the terms and conditions set forth in the New Forbearance Agreement, to forbear for a specified period of time from exercising its default-related rights and remedies (including the acceleration of the outstanding loans and charging interest at the specified default rate) with respect to the Specified Defaults under the Pinecone Loan Documents. The forbearance period under the New Forbearance Agreement is from September 6, 2018, the date on which certain conditions set forth in the New Forbearance Agreement were satisfied, to December 31, 2018, unless the forbearance period is earlier terminated as a result of specified termination events, including a default or event of default under the Pinecone Loan Documents (other than any Specified Defaults) or any failure by the Company or its subsidiaries to comply with the New Forbearance Agreement. Pursuant to the New Forbearance Agreement, the Company and Pinecone agreed to amend certain provisions of the Pinecone Loan Documents. Such amendments, among other things: (i) remove the restriction on prepaying the loans during the thirteen (13) month-period after the Closing Date; (ii) provide a thirty (30)-day cure period for certain events of default and a fifteen (15)-day cure period for certain failures to provide information or materials pursuant to the Pinecone Loan Documents; (iii) increase the finance fee payable on repayment or acceleration of the loans, depending on the time at which the loans are repaid ($0.25 million prior to December 31, 2018 and $0.5 million thereafter); and (iv) increase the outstanding principal balance owed by (a) approximately $0.7 million to reimburse Pinecone for its accrued and unpaid expenses and to pay outstanding interest payments for prior interest periods and (b) $1.5 million as a non-refundable payment of additional interest. During the forbearance period under the New Forbearance Agreement, the interest rate will revert from the default rate of 18.5% per annum to the ongoing rate of 13.5% per annum. Pursuant to the New Forbearance Agreement which amends the Pinecone Loan Documents, the Company hired a financial advisor (a “Financial Advisor”) reasonably acceptable to Pinecone to advise management and the Company’s board of directors on operational improvements and to assist in coordinating overall company strategy, whose engagement shall include assisting the Company to obtain one or more sources of refinancing to repay the obligations under the Pinecone Loan Documents. The New Forbearance Agreement also amends the Pinecone Credit Facility to permit the Company to substitute or replace the operators of certain of the Company’s facilities without the prior written consent of Pinecone, provided that such substitution or replacement is on commercially reasonable terms, has been approved by a Financial Advisor, and the terms of which have been disclosed to Pinecone no later than two (2) business days prior to entry into definitive documentation and Pinecone has not objected during such time period. The forbearance period under the New Forbearance Agreement expires on December 31, 2018, unless earlier terminated upon specified termination events. As of such date, Pinecone will no longer be required to forbear from exercising its default-related rights and remedies with respect to any Specified Defaults and may exercise all of its rights and remedies under the Pinecone Credit Facility at that time. For further information, see Note – 3 Liquidity . Debt Covenant Compliance As of September 30, 2018, the Company had approximately 23 credit related instruments outstanding that include various financial and administrative covenant requirements. Covenant requirements include, but are not limited to, fixed charge coverage ratios, debt service coverage ratios, minimum EBITDA or EBITDAR, and current ratios. Certain financial covenant requirements are based on consolidated financial measurements whereas others are based on measurements at the subsidiary level (i.e., facility, multiple facilities or a combination of subsidiaries). The subsidiary level requirements are as follows: (i) financial covenants measured against subsidiaries of the Company; and (ii) financial covenants measured against third-party operator performance. Some covenants are based on annual financial metric measurements whereas others are based on monthly and quarterly financial metric measurements. The Company routinely tracks and monitors its compliance with its covenant requirements. The Company is in compliance with its debt covenants other than those in the Pinecone Credit Facility. The Company was not in compliance with various non-financial covenants and the combined fixed charge coverage ratio required under the Pinecone Credit Facility as of September 30, 2018. The Pinecone Credit Facility requires the Company maintain a combined fixed charge coverage ratio of 1.2, and the Company’s combined fixed charge coverage ratio was equal to 1.0 as of September 30, 2018, such violation is waived for the duration of the New Forbearance Agreement period. For further information, see Note 3 – Liquidity. Scheduled Maturities The schedule below summarizes the scheduled gross maturities for the twelve months ended September 30 of the respective year: For the twelve months ended September 30, (Amounts in 000’s) 2019 $ 6,494 2020 (1) 20,940 2021 1,711 2022 5,161 2023 1,730 Thereafter 46,704 Subtotal $ 82,740 Less: unamortized discounts (167 ) Less: deferred financing costs, net (1,665 ) Total notes and other debt $ 80,908 (1) Unless accelerated by Pinecone, the Pinecone Credit Facility matures on August 15, 2020. |
Discontinued Operations
Discontinued Operations | 9 Months Ended |
Sep. 30, 2018 | |
Discontinued Operations And Disposal Groups [Abstract] | |
Discontinued Operations | NOTE 10. DISCONTINUED OPERATIONS For discontinued operations, cost of services, primarily accruals for professional and general liability claims and bad debt expense are classified in the activities below. For a historical listing and description of the Company’s discontinued entities, see Part II, Item 8, Financial Statements and Supplementary Data, – Discontinued Operations The following table summarizes the activity of discontinued operations for the three and nine September 30, 2018 2017 Three Months Ended September 30, Nine Months Ended September 30, (Amounts in 000’s) 2018 2017 2018 2017 Cost of services $ (159 ) $ 1,026 $ 235 $ 2,032 Interest expense, net 2 6 7 17 Net loss $ 157 $ (1,032 ) $ (242 ) $ (2,049 ) |
Common and Preferred Stock
Common and Preferred Stock | 9 Months Ended |
Sep. 30, 2018 | |
Stockholders Equity Note [Abstract] | |
Common and Preferred Stock | NOTE 11. COMMON AND PREFERRED STOCK Common and Preferred Stock Repurchase Activity In November 2016, the Board approved two share repurchase programs (collectively, the "November 2016 Repurchase Program"), pursuant to which AdCare was authorized to repurchase up to 1.0 million shares of the common stock and 100,000 shares of the Series A Preferred Stock during a twelve-month period. Share repurchases under the November 2016 Repurchase Program could be made from time to time through open market transactions, block trades or privately negotiated transactions and were subject to market conditions, as well as corporate, regulatory and other considerations. The Company could suspend or continue the November 2016 Repurchase Program at any time and had no obligation to repurchase any amount of the common stock or the Series A Preferred Stock under such program. The November 2016 Repurchase Program was suspended in February 2017. During the nine months ended September 30, 2017, the Company repurchased 118,199 shares of the common stock pursuant to the November 2016 Repurchase Program for $0.2 million at an average price of $1.54 per share, exclusive of commissions and related fees, and made no repurchases during the three months ended September 30, 2017 or the three and nine months ended September 30, 2018. During the three and nine months ended September 30, 2018 and 2017, respectively, the Company made no repurchases of the Series A Preferred Stock. Preferred Stock Offerings and Dividends No dividends were declared or paid on the Series A Preferred Stock for the three and nine months ended September 30, 2018. Dividends declared and paid on shares of the Series A Preferred Stock were $0.68 per share per quarter, or $1.9 million and $5.7 million respectively, for the three and nine months ended September 30, 2017. As of September 30, 2018, as a result of the suspension of the dividend payment on the Series A Preferred Stock for the fourth quarter 2017 and the first, second and third quarter 2018 dividend periods, the Company has $7.6 million of undeclared preferred stock dividends in arrears, or $1.9 million per quarter. On June 8, 2018, the Board determined to continue suspension of the payment of the quarterly dividend on the Series A Preferred Stock indefinitely. Holders of the Series A Preferred Stock are entitled to receive, when and as declared by the Board out of funds of the Company legally available for the payment of distributions, cumulative preferential cash dividends at an annual rate equal to 10.875% of the $25.00 per share stated liquidation preference of the Series A Preferred Stock, which is equivalent to an annual rate of $2.72 per share. Dividends on the Series A Preferred Stock are payable quarterly in arrears, on March 31, June 30, September 30, and December 31, of each year. Under the terms of the Series A Preferred Stock, dividends on the Series A Preferred Stock shall continue to accrue and accumulate regardless of whether such dividends are declared by the Board. The Company has failed to pay cash dividends on the outstanding Series A Preferred Stock in full for four consecutive dividends periods, meaning (i) the annual dividend rate on the Series A Preferred Stock will be increased to 12.875%, commencing on the first day after the missed fourth quarterly payment and continuing until the second consecutive dividend payment date following such time as the Company has paid all accumulated and unpaid dividends on the Series A Preferred Stock in full in cash; and (ii) the holders of the Series A Preferred Stock will be entitled to vote, as a single class, for the election of two additional directors to serve on the Board, as further described in the Company’s Amended and Restated Articles of Incorporation. As of September 30, 2018, the Company had 2,811,535 shares of the Series A Preferred Stock issued and outstanding. Holders of the Series A Preferred Stock generally have no voting rights but have limited voting rights under certain circumstances. The Company may, at its option, redeem the Series A Preferred Stock, in whole or in part, by paying $25.00 per share, plus any accrued and unpaid dividends to the redemption date. For historical information regarding the Series A Preferred Stock, the Company’s former “at-the-market” offering program and prior share repurchase programs, see Part II, Item 8, Financial Statements and Supplementary Data, Note 12 – Common and Preferred Stock |
Stock Based Compensation
Stock Based Compensation | 9 Months Ended |
Sep. 30, 2018 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Stock Based Compensation | NOTE 12. STOCK BASED COMPENSATION For the three and nine months ended September 30, 2018 2017 Three Months Ended September 30, Nine Months Ended September 30, (Amounts in 000’s) 2018 2017 2018 2017 Employee compensation: Restricted stock $ 4 $ 47 $ 11 $ 81 Warrants — 19 — 23 Total employee stock-based compensation expense $ 4 $ 66 $ 11 $ 104 Non-employee compensation: Board restricted stock $ 46 $ 48 $ 115 $ 140 Board stock options — 13 — 37 Total non-employee stock-based compensation expense $ 46 $ 61 $ 115 $ 177 Total stock-based compensation expense $ 50 $ 127 $ 126 $ 281 Stock Incentive Plan The AdCare Health Systems, Inc. 2011 Stock Incentive Plan, as amended (the “2011 Stock Incentive Plan”), was assumed by Regional Health pursuant to the Merger. As a result of the Merger, all rights to acquire shares of AdCare common stock under any AdCare equity incentive compensation plan have been converted into rights to acquire Regional Health common stock pursuant to the terms of the equity incentive compensation plans and other related documents, if any. The 2011 Stock Incentive Plan expires March 28, 2021 and provides for a maximum of 2,027,393 shares of common stock to be issued. The 2011 Stock Incentive Plan permits the granting of incentive or nonqualified stock options and the granting of restricted stock. The plan is administered by the Compensation Committee of the Board (the “Compensation Committee”), pursuant to authority delegated to it by the Board. The Compensation Committee is responsible for determining the employees to whom awards will be made, the amounts of the awards, and the other terms and conditions of the awards. As of September 30, 2018, the number of securities remaining available for future issuance is 233,296. In addition to the 2011 Stock Incentive Plan, the Company grants stock warrants to officers, directors, employees and certain consultants to the Company from time to time as determined by the Board and, when appropriate, the Compensation Committee. For the three and nine months ended September 30, 2018 2017 Common Stock Options The following table summarizes the Company’s common stock option activity for the nine months ended September 30, 2018: Number of Shares (000's) Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in 000's) Outstanding, December 31, 2017 181 $ 3.98 6.4 $ — Granted — $ — Forfeited — $ — Expired — $ — Outstanding and Vested, September 30, 2018 181 $ 3.98 5.6 $ — The following table summarizes the common stock options outstanding and exercisable as of September 30, 2018: Stock Options Outstanding Options Exercisable Exercise Price Number of Shares (000's) Weighted Average Remaining Contractual Term (in years) Weighted Average Exercise Price Vested, September 30, 2018 Weighted Average Exercise Price $1.31 - $3.99 115 6.0 $ 3.90 115 $ 3.90 $4.00 - $4.30 66 5.0 $ 4.12 66 $ 4.12 Total 181 5.6 $ 3.98 181 $ 3.98 Common Stock Warrants The following table summarizes the Company’s common stock warrant activity for the nine months ended September 30, 2018: Number of Warrants (000's) Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in 000's) Outstanding, December 31, 2017 1,019 $ 3.79 4.7 $ — Granted — $ — Forfeited — $ — Expired — $ — Outstanding and Vested, September 30, 2018 1,019 $ 3.79 3.9 $ — The following table summarizes the common stock warrants outstanding and exercisable as of September 30, 2018: Warrants Outstanding Warrants Exercisable Exercise Price Number of Shares (000's) Weighted Average Remaining Contractual Term (in years) Weighted Average Exercise Price Vested, September 30, 2018 Weighted Average Exercise Price $0 - $1.99 110 1.1 $ 1.93 110 $ 1.93 $2.00 - $2.99 110 1.1 $ 2.57 110 $ 2.57 $3.00 - $3.99 274 2.7 $ 3.71 274 $ 3.71 $4.00 - $4.99 502 5.8 $ 4.42 502 $ 4.42 $5.00 - $5.90 23 4.6 $ 5.90 23 $ 5.90 Total 1,019 3.9 $ 3.79 1,019 $ 3.79 Restricted Stock The following table summarizes the Company’s restricted stock activity for the nine months ended September 30, 2018: Number of Shares (000's) Weighted Avg. Grant Date Fair Value Unvested, December 31, 2017 152 $ 1.83 Granted 490 $ 0.30 Vested (61 ) $ 1.85 Forfeited — $ — Unvested, September 30, 2018 581 $ 0.54 For restricted stock unvested at September 30, 2018, $0.2 million in compensation expense will be recognized over the next 1.7 years. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2018 | |
Commitments And Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | NOTE 13. COMMITMENTS AND CONTINGENCIES Regulatory Matters Laws and regulations governing federal Medicare and state Medicaid programs are complex and subject to interpretation. Compliance with such laws and regulations can be subject to future governmental review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from certain governmental programs. As of September 30, 2018, all of the Company’s facilities leased and subleased to third-party operators and managed for third-parties are certified by the U.S. Department of Health and Human Services Centers for Medicare and Medicaid Services (“CMS”) and are operational (see Note 7 - Leases Legal Matters The Company is party to various legal actions and administrative proceedings and is subject to various claims arising in the ordinary course of business, including claims that the services the Company provided during the time it operated skilled nursing facilities resulted in injury or death to the patients of the Company’s facilities and claims related to professional and general negligence, employment, staffing requirements and commercial matters. Although the Company intends to vigorously defend itself in these matters, there is no assurance that the outcomes of these matters will not have a material adverse effect on the Company’s business, results of operations and financial condition. The Company previously operated, and the Company’s tenants now operate, in an industry that is extremely regulated. As such, in the ordinary course of business, the Company’s tenants are continuously subject to state and federal regulatory scrutiny, supervision and control. Such regulatory scrutiny often includes inquiries, investigations, examinations, audits, site visits and surveys, some of which are non-routine. In addition, we believe that there has been, and will continue to be, an increase in governmental investigations of long-term care providers, particularly in the area of Medicare/Medicaid false claims, as well as an increase in enforcement actions resulting from these investigations. Adverse determinations in legal proceedings or governmental investigations against or involving the Company, for the Company’s prior operations, or the Company’s tenants, whether currently asserted or arising in the future, could have a material adverse effect on the Company’s business, results of operations and financial condition. Professional and General Liability Claims . As of September 30, 2018, the Company is a defendant in 21 professional and general liability actions primarily commenced on behalf of former patients. These actions generally seek unspecified compensatory and punitive damages for former patients of the Company who were allegedly injured or died while patients of facilities operated by the Company due to professional negligence or understaffing. During the quarter ended September 30, 2018, the Company has settlements in principal with respect to seven of these actions, subject to certain conditions, as discussed below. Of the 14 actions not subject to settlement in principle, two such actions are covered by insurance, except that any award of punitive damages would be excluded from such coverage and five of such actions relate to events which occurred after the Company transitioned the operations of the facilities in question to a third-party operator and which are subject to such operators’ indemnification obligations in favor of the Company. On March 12, 2018, the Company entered into a separate mediation settlement agreement with respect to 25 actions filed in the State of Arkansas which were pending on such date. As discussed below, as of September 30, 2018, 18 of such actions have been dismissed with prejudice and seven of such actions remain subject to a settlement in principle. Each mediation settlement agreement provides for payment by the Company of a specified settlement amount, which settlement amount with respect to each action was deposited into the mediator’s trust account. The aggregate settlement amount for all such 25 actions before related insurance proceeds is $5.2 million. In connection with a dispute between the Company and the Company’s former commercial liability insurance provider regarding, among other things, the Company’s insurance coverage with respect to the 25 actions filed in the State of Arkansas, the former insurer filed a complaint in May 2016 against the Company seeking, among other things, a determination that the former insurer had properly exhausted the limits of liability of certain of the Company’s insurance policies issued by the former insurer, and the Company subsequently filed a counterclaim against the former insurer regarding such matters (collectively, the “Coverage Litigation”). On March 12, 2018, the former insurer and the Company entered into a settlement agreement (the “Coverage Settlement Agreement”), providing for, among other things, a settlement payment by the former insurer in the amount of approximately $2.8 million (the “Insurance Settlement Amount”), the dismissal with prejudice of the Coverage Litigation, a customary release of claims by the former insurer and the Company, and agreement that that the former insurer has exhausted the policies’ respective limits of liability and has no further obligations under the policies. Pursuant to the Coverage Settlement Agreement: (i) on March 16, 2018, the former insurer deposited the Insurance Settlement Amount into the trust account of the mediator with respect to the 25 actions; and (ii) on March Assuming, and subject to, the approval by the probate court of the settlement of the remaining seven actions subject to the agreement in principal and filed in the State of Arkansas and related matters, and the satisfaction of the other conditions with respect thereto, the Company will pay, net of the Insurance Settlement Amount, an aggregate of approximately $2.4 million in settlement of all 25 actions subject to the settlement in principle. The probate court approved settlements with respect to 15 of the 25 Arkansas actions during the quarter ended June 30, 2018 (having approved three in the first quarter of 2018), and approximately $3.3 million and $0.5 million, respectively, was paid from the mediator’s trust account in such settlements. The Company gives no assurance that the probate court will approve the settlement of the remaining seven Arkansas actions pending approval or that the other conditions to such settlements will be satisfied, or that such actions will be settled on the terms described herein or at all. In the second quarter of 2018, the Company settled one professional and general liability action (which was not subject to a mediation settlement agreement as discussed above) for a total of $50,000, payable in 10 monthly instalments commencing July 2018. In the second quarter of 2018, the Company was notified of one employment related action filed against the Company related to one of the Company’s discontinued operations. On August 1, 2018 the Company responded requesting dismissal without prejudice on multiple grounds, including being barred by the applicable statute of limitation. On October 4, 2018, the case against the Company was dismissed with prejudice. The Company established a self-insurance reserve for these professional and general liability claims, included within “Accrued expenses and other” in the Company’s consolidated balance sheets of $1.8 million and $5.1 million at September 30, 2018 and December 31, 2017, respectively. Additionally as of September 30, 2018 and December 31, 2017, $0.6 million and $0.5 million, respectively, was reserved for settlement amounts in “Accounts payable” in the Company’s consolidated balance sheets, and $0.2 million as of December 31, 2017, was reserved for settlement amounts in “Other liabilities”. For additional information regarding the Company’s self-insurance reserve, see Part II, Item 8, Financial Statements and Supplementary Data, – Commitments and Contingencies Aria Bankruptcy Proceeding . On May 31, 2016, Highlands Arkansas Holdings, LLC, an affiliate of Aria (“HAH”) and nine affiliates of HAH (collectively with HAH, the “Debtors”), filed petitions in the United States Bankruptcy Court for the District of Delaware for relief under Chapter 7 of the United States Bankruptcy Code. Following venue transfer from the Delaware court, these cases are pending in the United States Bankruptcy Court for the Eastern District of Arkansas. On July 17, 2015, the Company made a short-term loan to HAH, for working capital purposes, and, in connection therewith, HAH executed a promissory note (the “HAH Note”) in favor of the Company. Since July 17, 2015, the HAH Note has been amended from time to time and currently has an outstanding principal balance of $1.0 million that matured on December 31, 2015. On October 6, 2015, HAH and the Company entered into a security agreement, whereby HAH granted the Company a security interest in all accounts arising from the business of HAH and the Aria Sublessees, and all rights to payment from patients, residents, private insurers and others arising from the business of HAH and the Aria Sublessees (including any proceeds thereof), as security for payment of the HAH Note, as amended, and certain rent and security deposit obligations of the Aria Sublessees under Aria Subleases. On April 21, 2017, the Company moved for relief from the automatic stay seeking release of its collateral, the Debtors’ accounts and their proceeds, the value of which the trustee has represented as a total of approximately $0.8 million. The Chapter 7 trustee and another creditor opposed the Company’s motion in May 2017. In its objection, the Chapter 7 trustee asserts that the Company is not entitled to any of the $0.8 million with respect to the HAH Note. In addition to opposing the Company’s claim to the $0.8 million, the Chapter 7 trustee has also indicated he was investigating avoidance claims against the Company with respect to funds the Company received from the Debtors prior to the bankruptcy filings. On March 28, 2018, such avoidance case was filed, requesting relief in an amount of $4.7 million, which the Company believes to be without merit and intends to vigorously defend against. The case is scheduled for a hearing during February 2019. For the year ended December 31, 2017, the Company has charged approximately $0.6 million to bad debt expense on the HAH Note. The Company believes it acted in good faith and as it is the only secured creditor believes that the remaining balance on the HAH Note is collectible. There is no guarantee that the bankruptcy court will approve repayment of the HAH Note to the Company or that the Company will prevail in the avoidance action that has been filed against it. Employer Shared Responsibility Payment On April 2, 2018, the Company received notification from the Internal Revenue Service (“IRS”), on Letter 226-J, that the Company may be liable for an Employer Shared Responsibility Payment (“ESRP”) in the amount of $2.9 million for the year ended December 31, 2015. On April 10, 2018, the Company responded to the IRS with appropriate documentation to prove the Company has no ESRP liability, and on May 8, 2018, the Company received written confirmation from the IRS that is in agreement with the Company’s findings. Pinecone Credit Facility Contingent Finance Fees Pursuant to the New Forbearance Agreement, the Company and Pinecone agreed to increase the finance fee payable on repayment or acceleration of the loans, depending on the time at which the loans are repaid, with such fee being $0.25 million prior to December 31, 2018 and $0.5 million thereafter. For further information, see Note 3 – Liquidity 9 – Notes Payable and Other Debt. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Sep. 30, 2018 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | NOTE 14. RELATED PARTY TRANSACTIONS McBride Matters During the three months ended September 30, 2018, the Company paid $39,082 to Mr. McBride, the Company’s former Chief Executive Officer and a former director, pursuant to the McBride Settlement Agreement. For additional information regarding the Company’s related party transactions, see Part II, Item 8, Financial Statements and Supplementary Data, – Related Party Transactions |
Subsequent Events
Subsequent Events | 9 Months Ended |
Sep. 30, 2018 | |
Subsequent Events [Abstract] | |
Subsequent Events | NOTE 15. SUBSEQUENT EVENTS The Company has evaluated all subsequent events through the date the consolidated financial statements were issued and filed with the SEC. Skyline Note On October 12, 2018, the Company accepted a payment of approximately $1.0 million in full satisfaction of the Skyline Note, which represents a discount from the full amount of $3.0 million outstanding thereunder. In connection with such payment the Company agreed to release the Guarantors from their obligations under the Guaranty (see Note 7 – Leases |
Organization and Significant _2
Organization and Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2018 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations for the periods presented have been included. Operating results for the three and nine months ended September 30, 2018 and 2017 are not necessarily indicative of the results that may be expected for the fiscal year. The balance sheet at December 31, 2017 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. You should read the unaudited consolidated financial statements in this Quarterly Report together with the historical audited consolidated financial statements of the Company for the year ended December 31, 2017, included in the Annual Report. See Part II, Item 8, Financial Statements and Supplementary Data , Summary of Significant Accounting Policies Recently Adopted Standards. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. |
Revenue Recognition and Allowances | Revenue Recognition and Allowances Triple-Net Leased Properties. The Company's triple-net leases provide for periodic and determinable increases in rent. The Company recognizes rental revenues under these leases on a straight-line basis over the applicable lease term when collectability is probable. Recognizing rental income on a straight-line basis generally results in recognized revenues during the first half of a lease term exceeding the cash amounts contractually due from our tenants, creating a straight-line rent receivable that is included in straight-line rent receivable on our consolidated balance sheets. In the event the Company cannot reasonably estimate the future collection of rent from one or more tenant(s) of the Company’s facilities, rental income for the affected facilities will be recognized only upon cash collection, and any accumulated straight-line rent receivable will be reversed in the period in which the Company deems rent collection no longer probable. Rental revenues for five facilities located in Ohio and one facility in North Carolina are recorded on a cash basis (for additional information with respect to such facilities, see Note 7 ). Allowances. The Company assesses the collectability of its rent receivables, including straight-line rent receivables and working capital loans to tenants. The Company bases its assessment of the collectability of rent receivables and working capital loans to tenants on several factors, including payment history, the financial strength of the tenant and any guarantors, the value of the underlying collateral, and current economic conditions. If the Company's evaluation of these factors indicates it is probable that the Company will be unable to receive the rent payments or payments on a working capital loan, then the Company provides a reserve against the recognized straight-line rent receivable asset or working capital loan for the portion that we estimate may not be recovered. If the Company changes its assumptions or estimates regarding the collectability of future rent payments required by a lease or required from a working capital loan to a tenant, then the Company may adjust its reserve to increase or reduce the rental revenue or interest revenue from working capital loans to tenants recognized in the period the Company makes such change in its assumptions or estimates, see Note 7 ). As of September 30, 2018 and December 31, 2017, the Company reserved for approximately $1.4 million and $2.6 million, respectively, of gross patient care related receivables arising from its legacy operations. Allowances for patient care receivables are estimated based on an aged bucket method as well as additional analyses of remaining balances incorporating different payor types. Any changes in patient care receivable allowances are recognized as a component of discontinued operations. All uncollected patient care receivables were fully reserved at September 30, 2018 and December 31, 2017. Accounts receivable, net, totaled $0.9 million at September 30, 2018 and $0.9 million at December 31, 2017. |
Extinguishment of Debt | Extinguishment of Debt The Company recognizes extinguishment of debt when the criteria for a troubled debt restructure are not met and the change in |
Pre-paid expenses and other | Pre-paid expenses and other As of September 30, 2018 and December 31, 2017, the Company had $0.3 million and $0.3 million, respectively, in pre-paid expenses and other, primarily for directors’ and officers’ insurance and mortgage insurance premiums. |
Self Insurance | Self-Insurance The Company has self-insured against professional and general liability claims since it discontinued its healthcare operations during 2014 and 2015 in connection with its transition from an owner and operator of healthcare properties to a healthcare property holding and leasing company (see Part II, Item 8, Financial Statements and Supplementary Data , – Commitments and Contingencies – Accrued Expenses and Other |
Other operating expenses and Other expense | Other o p Other operating expenses decreased by approximately $0.2 million, or 50.7%, to $0.3 million for the three months ended September 30, 2018, compared with $0.5 million for the same period in 2017. The decrease is due to: (i) a $0.3 million settlement expense related to Mr. McBride, the Company’s former Chief Executive Officer and Chairman of the Board, in the prior year period; and (ii) $0.1 million investigation expense related to an internal investigation in the prior year period, offset by: (i) $0.1 million accrual for property taxes related to facilities whose rent payments are being recognized on a cash received basis; and (ii) approximately $0.1 million increase in contract services. Other expense decreased by $0.1 million, or 100.0%, for the three months ended September 30, 2018, compared with $0.1 million for the same period in 2017 and decreased by $0.4 million, or 97.4%, for the nine months ended September 30, 2018, compared with $0.4 million for the same period in 2017. The prior period charge was related to expenses for the Merger. |
Reclassifications | Reclassifications Certain reclassifications have been made to the 2017 financial information to conform to the 2018 presentation with no effect on the Company's consolidated financial position or results of operations. These reclassifications did not affect total assets, total liabilities, or stockholders' equity. Reclassifications were made to the consolidated statements of operations for the three and nine months ended September 30, 2017 to conform the presentation of: (i) management fee revenues and its related expense, previously reported as general and administrative expense; and (ii) provision for doubtful accounts previously reported as Other operating expenses. Reclassifications were made to the consolidated statements of cash flows for the nine months ended September 30, 2017 to include restricted cash in cash and restricted cash at the beginning-of-period and end-of-period totals. |
Recently Adopted Standards and Significant Accounting Pronouncements | Recently On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers Accounting Standards Codification ASC”) The Company has one contract (the “Management Contract”) to manage two skilled nursing facilities and one independent living facility for a third party, with payment for each month of service received in full on a monthly basis. Companies are permitted to adopt the standard using a retrospective transition method (i.e., restate all prior periods presented) or a cumulative effect method (i.e., recognize the cumulative effect of initially applying the guidance at the date of initial application with no restatement of prior periods). However, both methods allow companies to elect certain practical expedients on transition that will help to simplify how a company restates its contracts. The Company adopted the standard using the cumulative effect method. As a result of the adoption of this guidance, for the three and nine months ended September 30, 2017, the Company reclassified expenses related to the Management Contract from General and administrative expense to Cost of management fees on the consolidated statements of operations. In August 2016, the FASB issued ASU 2016-1 Classification of Certain Cash Receipts and Cash Payments ASU 2016-15 In November 2016, the FASB issued ASU 2016-18 Restricted Cash ASU 2016-18 Recent Significant Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02 Leases ASU 2018-11, Leases (Topic 842) Targeted Improvements, ASU 2016-02 ASU 2016-02 ASU 2018-11 See Part II, Item 8, Financial Statements and Supplementary Data , Summary of Significant Accounting Policies |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Earnings Per Share [Abstract] | |
Reconciliation of Net Income (Loss) for Continuing and Discontinued Operations and the Number of Common Shares Used in the Computation of Both Basic and Diluted Earnings Per Share | The following tables provide a reconciliation of net income (loss) for continuing and discontinued operations and the number of shares of common stock used in the computation of both basic and diluted earnings per share: Three Months Ended September 30, Nine Months Ended September 30, (Amounts in 000’s, except per share data) 2018 2017 2018 2017 Numerator: (Loss) income from continuing operations $ (4,666 ) $ 266 $ (10,011 ) $ 351 Preferred stock dividends - declared — (1,912 ) — (5,702 ) Preferred stock dividends - undeclared (1) (1,912 ) — (5,736 ) — Basic and diluted loss from continuing operations (6,578 ) (1,646 ) (15,747 ) (5,351 ) Income (loss) from discontinued operations, net of tax 157 (1,032 ) (242 ) (2,049 ) Net loss attributable to Regional Health Properties, Inc. common stockholders $ (6,421 ) $ (2,678 ) $ (15,989 ) $ (7,400 ) Denominator: Basic - weighted average shares 20,187 19,762 19,914 19,784 Diluted - adjusted weighted average shares (2) 20,187 19,762 19,914 19,784 Basic and diluted loss per share: Loss from continuing operations attributable to Regional Health $ (0.33 ) $ (0.08 ) $ (0.79 ) $ (0.27 ) Income (loss) from discontinued operations 0.01 (0.05 ) (0.01 ) (0.10 ) Loss attributable to Regional Health Properties, Inc. common stockholders $ (0.32 ) $ (0.13 ) $ (0.80 ) $ (0.37 ) (1) The Board suspended dividend payments with respect to the Series A Preferred Stock for the fourth quarter 2017, the first, second and third quarter 2018. On June 8, 2018, the Board determined to continue suspension of the payment of the quarterly dividend indefinitely. (2) Securities outstanding that were excluded from the computation, because they would have been anti-dilutive were as follows: September 30, (Share amounts in 000’s) 2018 2017 Stock options 181 245 Warrants - employee 582 1,350 Warrants - non employee 437 437 Shares issuable upon conversion of convertible debt — 353 Total anti-dilutive securities 1,200 2,385 |
Schedule of Securities Outstanding that were Excluded From the Computation, Prior to the Use of the Treasury Stock Method, Because They Would Have Been Anti-dilutive | (1) The Board suspended dividend payments with respect to the Series A Preferred Stock for the fourth quarter 2017, the first, second and third quarter 2018. On June 8, 2018, the Board determined to continue suspension of the payment of the quarterly dividend indefinitely. (2) Securities outstanding that were excluded from the computation, because they would have been anti-dilutive were as follows: September 30, (Share amounts in 000’s) 2018 2017 Stock options 181 245 Warrants - employee 582 1,350 Warrants - non employee 437 437 Shares issuable upon conversion of convertible debt — 353 Total anti-dilutive securities 1,200 2,385 |
Cash and Restricted Cash (Table
Cash and Restricted Cash (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Restricted Cash And Investments [Abstract] | |
Schedule Of Cash And Restricted Cash | The following presents the Company's cash and restricted cash: (Amounts in 000’s) September 30, 2018 December 31, 2017 Cash $ 1,884 $ 1,818 Restricted cash: Cash collateral 44 63 Replacement reserves 297 260 Escrow deposits 768 637 Total current portion 1,109 960 Restricted cash for debt obligations 365 405 HUD and other replacement reserves 2,265 2,176 Total noncurrent portion 2,630 2,581 Total restricted cash 3,739 3,541 Total cash and restricted cash $ 5,623 $ 5,359 |
Property and Equipment (Tables)
Property and Equipment (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Property Plant And Equipment [Abstract] | |
Schedule of Property and Equipment | The following table sets forth the Company’s property and equipment: (Amounts in 000’s) Estimated Useful Lives (Years) September 30, 2018 December 31, 2017 Buildings and improvements 5-40 $ 89,624 $ 89,665 Equipment and computer related 2-10 9,634 10,893 Land — 4,137 4,248 Construction in process — 231 49 103,626 104,855 Less: accumulated depreciation and amortization (25,052 ) (23,642 ) Property and equipment, net $ 78,574 $ 81,213 The following table summarizes total depreciation and amortization expense for the three and nine months ended September 30, 2018 and 2017: Three Months Ended September 30, Nine Months Ended September 30, (Amounts in 000’s) 2018 2017 2018 2017 Depreciation $ 788 $ 857 $ 2,394 $ 2,486 Amortization 338 336 1,113 1,013 Total depreciation and amortization expense $ 1,126 $ 1,193 $ 3,507 $ 3,499 |
Intangible Assets and Goodwill
Intangible Assets and Goodwill (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Goodwill And Intangible Assets Disclosure [Abstract] | |
Schedule of Intangible Assets | Intangible assets consist of the following: (Amounts in 000’s) Bed licenses (included in property and equipment) (a) Bed Licenses - Separable Lease Rights Total Balances, December 31, 2017 Gross $ 22,811 $ 2,471 $ 7,181 $ 32,463 Accumulated amortization (4,166 ) — (4,994 ) (9,160 ) Net carrying amount $ 18,645 $ 2,471 $ 2,187 $ 23,303 Amortization expense (512 ) — (601 ) (1,113 ) Balances, September 30, 2018 Gross 22,811 2,471 7,181 32,463 Accumulated amortization (4,678 ) — (5,595 ) (10,273 ) Net carrying amount $ 18,133 $ 2,471 $ 1,586 $ 22,190 (a) Non-separable bed licenses are included in property and equipment as is the related accumulated amortization expense (see Note 5 – Property and Equipment |
Schedule of Total Amortization Expense | The following table summarizes amortization expense for the three and nine months ended September 30, 2018 and 2017: Three Months Ended September 30, Nine Months Ended September 30, (Amounts in 000’s) 2018 2017 2018 2017 Bed licenses $ 171 $ 169 $ 512 $ 512 Lease rights 167 167 601 501 Total amortization expense $ 338 $ 336 $ 1,113 $ 1,013 |
Schedule of Estimated Amortization Expense for All Definite Lived Intangibles | Expected amortization expense for all definite-lived intangibles for each of the years ended December 31 is as follows: (Amounts in 000’s) Bed Licenses Lease Rights 2018 (a) $ 171 $ 166 2019 683 667 2020 683 482 2021 683 203 2022 683 68 Thereafter 15,230 - Total expected amortization expense $ 18,133 $ 1,586 (a) Estimated amortization expense for the year ending December 31, 2018, includes only amortization to be recorded after September 30, 2018. |
Summary of the Changes in the Carrying Amount of Goodwill | The following table summarizes the carrying amount of goodwill: (Amounts in 000’s) September 30, 2018 December 31, 2017 Goodwill $ 2,945 $ 2,945 Accumulated impairment losses (840 ) (840 ) Net carrying amount $ 2,105 $ 2,105 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Leases [Abstract] | |
Schedule of Future Minimum Lease Payments | Future minimum lease payments for each of the next five years ending December 31, are as follows: (Amounts in 000’s) 2018 (a) $ 2,118 2019 8,526 2020 8,677 2021 8,830 2022 9,026 Thereafter 37,430 Total $ 74,607 (a) Estimated minimum lease payments for the year ending December 31, 2018 include only payments to be paid after September 30, 2018. |
Summary of Annualized Cash Rent for Lease Agreements | The annualized 2018 cash rent under the lease agreements for the Ohio Beacon Facilities is shown below: Initial Lease Term 2018 Cash 2018 Cash Annual Rent Annual Rent Facility Name Operating Beds/Units Structure Commencement Date Expiration Date (Amounts in 000’s) % of Total Expected Ohio Covington Care 94 Leased 8/1/2015 4/30/2025 $ 818 3.7 % Eaglewood ALF 80 Owned 8/1/2015 7/31/2025 764 3.4 % Eaglewood Care Center 99 Owned 8/1/2015 7/31/2025 764 3.4 % H&C of Greenfield 50 Owned 8/1/2015 7/31/2025 382 1.7 % The Pavilion Care Center 50 Owned 8/1/2015 7/31/2025 382 1.7 % Total 373 $ 3,110 13.9 % |
Schedule of Net of Allowance and Annualized Cash Under Lease Agreement | Balances, net of allowances as of September 30, 2018 and annualized cash rent under the lease agreements for the Symmetry affiliated facilities is shown below: (Amounts in 000’s) Facility Name Revenue Recognition Straight- Line Rent Asset Other Receivables 2018 Original Cash Annual Rent** % of Total Original Expected 2018 Cash Annual Rent** Annualized Rent Concession Granted* North Carolina Mountain Trace Cash basis $ — $ — $ 742 3.3 % $ 382 South Carolina Sumter Straight-line 537 409 836 3.8 % 236 Georgetown Straight-line 216 107 338 1.5 % 26 $ 753 $ 516 $ 1,916 8.6 % $ 644 *Effective September 1, 2018. ** Excludes concession granted |
Schedule of Future Minimum Rental Payments Receivable for Operating Leases | Future minimum lease receivables from the Company’s facilities leased and subleased to third party tenants for each of the next five years ending December 31, are as follows: (Amounts in 000's) (b) 2018 (a) $ 4,660 2019 18,610 2020 19,040 2021 19,515 2022 20,002 Thereafter 94,216 Total $ 176,043 (a) Estimated minimum lease payments for the year ending December 31, 2018 include only payments to be paid after September 30, 2018. (b) Excludes amounts for the Ohio Beacon Facilities and Mountain Trace Tenant, and updated to reflect Symmetry Rent Concession. |
Accrued Expenses and Other (Tab
Accrued Expenses and Other (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Payables And Accruals [Abstract] | |
Schedule of Accrued Expenses | Accrued expenses and other consist of the following: (Amounts in 000’s) September 30, 2018 December 31, 2017 Accrued employee benefits and payroll-related $ 309 $ 290 Real estate and other taxes 704 423 Self-insured reserve (1) 1,832 5,077 Accrued interest 401 260 Other accrued expenses 974 972 Total accrued expenses and other $ 4,220 $ 7,022 (1) The Company self-insures against professional and general liability claims and uses a third party administrator and outside counsel to manage and defend the claims. Additionally, for the year ended December 31, 2017, $0.2 million was accrued in “Other liabilities” in the Company’s consolidated balance sheets for amounts due in excess of twelve months, (see Note 13 - Commitments and Contingencies) |
Notes Payable and Other Debt (T
Notes Payable and Other Debt (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Debt Disclosure [Abstract] | |
Schedule of Notes Payable and Other Debt | Notes payable and other debt consists of the following: (Amounts in 000’s) September 30, 2018 December 31, 2017 Senior debt—guaranteed by HUD $ 33,066 $ 33,685 Senior debt—guaranteed by USDA (a) 13,831 20,320 Senior debt—guaranteed by SBA (b) 673 2,210 Senior debt—bonds 6,960 7,055 Senior debt—other mortgage indebtedness 27,398 9,486 Other debt 812 1,050 Convertible debt — 1,500 Subtotal 82,740 75,306 Deferred financing costs (1,665 ) (2,027 ) Unamortized discount on bonds (167 ) (177 ) Total debt 80,908 73,102 Less: current portion of debt 25,744 8,090 Notes payable and other debt, net of current portion $ 55,164 $ 65,012 (a) (b) The following is a detailed listing of the debt facilities that comprise each of the above categories: (Amounts in 000’s) Facility Lender Maturity Interest Rate (a) September 30, 2018 December 31, 2017 Senior debt - guaranteed by HUD (b) The Pavilion Care Center Red Mortgage 12/01/2027 Fixed 4.16 % $ 1,247 $ 1,329 Hearth and Care of Greenfield Red Mortgage 08/01/2038 Fixed 4.20 % 2,078 2,127 Woodland Manor Midland State Bank 10/01/2044 Fixed 3.75 % 5,246 5,334 Glenvue Midland State Bank 10/01/2044 Fixed 3.75 % 8,145 8,283 Autumn Breeze KeyBank 01/01/2045 Fixed 3.65 % 7,081 7,199 Georgetown Midland State Bank 10/01/2046 Fixed 2.98 % 3,584 3,644 Sumter Valley KeyBank 01/01/2047 Fixed 3.70 % 5,685 5,769 Total $ 33,066 $ 33,685 Senior debt - guaranteed by USDA (c) Attalla (e) Metro City 09/30/2035 Prime + 1.50% 5.50 % $ — $ 6,169 Coosa Metro City 09/30/2035 Prime + 1.50% 6.75 % 5,431 5,562 Mountain Trace Community B&T 01/24/2036 Prime + 1.75% 7.00 % 4,166 4,260 Southland Bank of Atlanta 07/27/2036 Prime + 1.50% 6.75 % 4,234 4,329 Total $ 13,831 $ 20,320 Senior debt - guaranteed by SBA (d) College Park (e) CDC 10/01/2031 Fixed 2.81 % $ — $ 1,523 Southland Bank of Atlanta 07/27/2036 Prime + 2.25% 7.50 % 673 687 Total $ 673 $ 2,210 (a) (b) (c) (d) (e) (Amounts in 000’s) Facility Lender Maturity Interest Rate (a) September 30, 2018 December 31, 2017 Senior debt - bonds Eaglewood Bonds Series A City of Springfield, Ohio 05/01/2042 Fixed 7.65 % $ 6,610 $ 6,610 Eaglewood Bonds Series B City of Springfield, Ohio 05/01/2021 Fixed 8.50 % 350 445 Total $ 6,960 $ 7,055 (a) (Amounts in 000’s) Facility Lender Maturity Interest Rate (a) September 30, 2018 December 31, 2017 Senior debt - other mortgage indebtedness Quail Creek (c) Congressional Bank 04/30/2019 LIBOR + 4.75% 5.75 % $ 4,136 $ 4,314 Northwest (d) First Commercial 07/31/2020 Prime 5.00 % — 1,122 Meadowood Exchange Bank of Alabama 05/01/2022 Fixed 4.50 % 3,951 4,050 College Park Pinecone (b) 08/15/2020 Fixed 13.50 % 2,727 — Northwest Pinecone (b) 08/15/2020 Fixed 13.50 % 2,685 — Attalla Pinecone (b) 08/15/2020 Fixed 13.50 % 8,705 — Adcare Property Holdings Pinecone (b) 08/15/2020 Fixed 13.50 % 5,194 — Total $ 27,398 $ 9,486 (a) (b) On February 15, 2018, the Company entered into the Pinecone Credit Facility with Pinecone. On September 6, 2018, the Company entered into the New Forbearance Agreement, which provided for certain amendments to the Pinecone Credit Facility (for further information see, “Pinecone Credit Facility” below in this Note). (c) On April 30, 2018, the Company extended the maturity date of the Quail Creek Credit Facility to April 30, 2019. (d) On February 15, 2018, the Company repaid this loan with proceeds from the Pinecone Credit Facility. (Amounts in 000’s) Lender Maturity Interest Rate September 30, 2018 December 31, 2017 Other debt First Insurance Funding 03/01/2019 Fixed 4.24 % $ 81 $ 20 Key Bank 08/02/2019 Fixed 0.00 % 495 495 McBride Note (a) 09/30/2019 Fixed 4.00 % 153 264 Pharmacy Care of Arkansas 02/08/2018 Fixed 2.00 % — 42 South Carolina Department of Health & Human Services (b) 02/24/2019 Fixed 5.75 % 83 229 Total $ 812 $ 1,050 (a) (b) (Amounts in 000’s) Facility Maturity Interest Rate September 30, 2018 December 31, 2017 Convertible debt Issued July 2012 (a) 04/30/2018 Fixed 14.00 % $ — $ 1,500 Total $ — $ 1,500 (a) On February 15, 2018, the Company repaid the outstanding principal balance to Cantone Asset Management, LLC, together with accrued interest thereon, with proceeds from the Pinecone Credit Facility. |
Summary of the Scheduled Maturities | The schedule below summarizes the scheduled gross maturities for the twelve months ended September 30 of the respective year: For the twelve months ended September 30, (Amounts in 000’s) 2019 $ 6,494 2020 (1) 20,940 2021 1,711 2022 5,161 2023 1,730 Thereafter 46,704 Subtotal $ 82,740 Less: unamortized discounts (167 ) Less: deferred financing costs, net (1,665 ) Total notes and other debt $ 80,908 (1) Unless accelerated by Pinecone, the Pinecone Credit Facility matures on August 15, 2020. |
Discontinued Operations (Tables
Discontinued Operations (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Discontinued Operations And Disposal Groups [Abstract] | |
Schedule of Operations, Assets and Liabilities of the Disposal Groups Held for Sale | The following table summarizes the activity of discontinued operations for the three and nine September 30, 2018 2017 Three Months Ended September 30, Nine Months Ended September 30, (Amounts in 000’s) 2018 2017 2018 2017 Cost of services $ (159 ) $ 1,026 $ 235 $ 2,032 Interest expense, net 2 6 7 17 Net loss $ 157 $ (1,032 ) $ (242 ) $ (2,049 ) |
Stock Based Compensation (Table
Stock Based Compensation (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Summary of Recognized Stock Based Compensation | For the three and nine months ended September 30, 2018 2017 Three Months Ended September 30, Nine Months Ended September 30, (Amounts in 000’s) 2018 2017 2018 2017 Employee compensation: Restricted stock $ 4 $ 47 $ 11 $ 81 Warrants — 19 — 23 Total employee stock-based compensation expense $ 4 $ 66 $ 11 $ 104 Non-employee compensation: Board restricted stock $ 46 $ 48 $ 115 $ 140 Board stock options — 13 — 37 Total non-employee stock-based compensation expense $ 46 $ 61 $ 115 $ 177 Total stock-based compensation expense $ 50 $ 127 $ 126 $ 281 |
Summary of Company's Stock Option Activity | The following table summarizes the Company’s common stock option activity for the nine months ended September 30, 2018: Number of Shares (000's) Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in 000's) Outstanding, December 31, 2017 181 $ 3.98 6.4 $ — Granted — $ — Forfeited — $ — Expired — $ — Outstanding and Vested, September 30, 2018 181 $ 3.98 5.6 $ — |
Schedule of Exercise Price Range | The following table summarizes the common stock options outstanding and exercisable as of September 30, 2018: Stock Options Outstanding Options Exercisable Exercise Price Number of Shares (000's) Weighted Average Remaining Contractual Term (in years) Weighted Average Exercise Price Vested, September 30, 2018 Weighted Average Exercise Price $1.31 - $3.99 115 6.0 $ 3.90 115 $ 3.90 $4.00 - $4.30 66 5.0 $ 4.12 66 $ 4.12 Total 181 5.6 $ 3.98 181 $ 3.98 |
Summary of Company's Restricted Stock Activity | The following table summarizes the Company’s restricted stock activity for the nine months ended September 30, 2018: Number of Shares (000's) Weighted Avg. Grant Date Fair Value Unvested, December 31, 2017 152 $ 1.83 Granted 490 $ 0.30 Vested (61 ) $ 1.85 Forfeited — $ — Unvested, September 30, 2018 581 $ 0.54 |
Warrant | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Schedule of Exercise Price Range | The following table summarizes the common stock warrants outstanding and exercisable as of September 30, 2018: Warrants Outstanding Warrants Exercisable Exercise Price Number of Shares (000's) Weighted Average Remaining Contractual Term (in years) Weighted Average Exercise Price Vested, September 30, 2018 Weighted Average Exercise Price $0 - $1.99 110 1.1 $ 1.93 110 $ 1.93 $2.00 - $2.99 110 1.1 $ 2.57 110 $ 2.57 $3.00 - $3.99 274 2.7 $ 3.71 274 $ 3.71 $4.00 - $4.99 502 5.8 $ 4.42 502 $ 4.42 $5.00 - $5.90 23 4.6 $ 5.90 23 $ 5.90 Total 1,019 3.9 $ 3.79 1,019 $ 3.79 |
Schedule of Common Stock Warrant Activity | The following table summarizes the Company’s common stock warrant activity for the nine months ended September 30, 2018: Number of Warrants (000's) Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in 000's) Outstanding, December 31, 2017 1,019 $ 3.79 4.7 $ — Granted — $ — Forfeited — $ — Expired — $ — Outstanding and Vested, September 30, 2018 1,019 $ 3.79 3.9 $ — |
Organization and Significant _3
Organization and Significant Accounting Policies - Additional Information (Details) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2018USD ($)Facility | Sep. 30, 2017USD ($) | Sep. 30, 2018USD ($)Facility | Sep. 30, 2017USD ($) | Dec. 31, 2017USD ($) | |
Operating Leased Assets [Line Items] | |||||
Number of facilities | Facility | 30 | 30 | |||
Number of sublease agreements executed, owned by company | Facility | 14 | ||||
Number of sublease agreements executed, leased by company | Facility | 11 | 11 | |||
Number of assisted living facilities | Facility | 2 | ||||
Number of skilled nursing facilities | Facility | 2 | ||||
Number of independent living facilities | Facility | 1 | 1 | |||
Patient care receivables, estimated allowance for uncollectible accounts | $ 1,414 | $ 1,414 | $ 2,570 | ||
Accounts receivable, net of allowance | 887 | 887 | 945 | ||
Prepaid expenses and other | 263 | 263 | 304 | ||
Approximate increase (decrease) in operating expenses | $ (200) | ||||
Approximate increase (decrease) in operating expenses percentage | (50.70%) | ||||
Other operating expenses | $ 255 | $ 517 | 823 | $ 940 | |
Investigation Expense | 100 | ||||
Accrual for property taxes | 100 | ||||
Contract services | 100 | ||||
Increase (Decrease) in other expenses | (100) | (400) | |||
Other expense | $ 0 | $ 105 | $ 10 | $ 388 | |
Increase (Decrease) in other expenses percentage | (100.00%) | (97.40%) | |||
McBride | |||||
Operating Leased Assets [Line Items] | |||||
Settlement expense | $ 300 | ||||
Patient Care Receivables | |||||
Operating Leased Assets [Line Items] | |||||
Patient care receivables, estimated allowance for uncollectible accounts | $ 1,400 | $ 1,400 | $ 2,600 | ||
Triple-Net Leased Properties | Ohio | |||||
Operating Leased Assets [Line Items] | |||||
Number of facilities for which rent revenues are recorded on cash basis | Facility | 5 | 5 | |||
Triple-Net Leased Properties | North Carolina | |||||
Operating Leased Assets [Line Items] | |||||
Number of facilities for which rent revenues are recorded on cash basis | Facility | 1 | 1 | |||
Series A Preferred Stock | |||||
Operating Leased Assets [Line Items] | |||||
Cumulative preferential cash dividend rate | 10.875% |
Earnings Per Share - Additional
Earnings Per Share - Additional Information (Details) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Earnings Per Share [Abstract] | ||||
Antidilutive securities | 1,200 | 2,400 | 1,200 | 2,385 |
Earnings Per Share - Schedule o
Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Earnings Per Share [Line Items] | ||||
(Loss) income from continuing operations | $ (4,666) | $ 266 | $ (10,011) | $ 351 |
Preferred stock dividends - declared | 0 | 1,912 | 0 | 5,702 |
Preferred stock dividends - undeclared | 1,912 | 0 | 5,736 | 0 |
Income (loss) from discontinued operations, net of tax | 157 | (1,032) | (242) | (2,049) |
Net loss attributable to Regional Health Properties, Inc. common stockholders | $ (6,421) | $ (2,678) | $ (15,989) | $ (7,400) |
Basic earnings per share - weighted average shares (in shares) | 20,187 | 19,762 | 19,914 | 19,784 |
Diluted - adjusted weighted average shares | 20,187 | 19,762 | 19,914 | 19,784 |
Basic and diluted loss per share: | ||||
Loss from continuing operations attributable to Regional Health (in dollars per share) | $ (0.33) | $ (0.08) | $ (0.79) | $ (0.27) |
Net loss per share of common stock attributable to Regional Health Properties, Inc. | (0.32) | (0.13) | (0.80) | (0.37) |
Income (loss) from discontinued operations (in dollars per share) | $ 0.01 | $ (0.05) | $ (0.01) | $ (0.10) |
Continuing Operations | ||||
Earnings Per Share [Line Items] | ||||
Net loss attributable to Regional Health Properties, Inc. common stockholders | $ (6,578) | $ (1,646) | $ (15,747) | $ (5,351) |
Earnings Per Share - Anti-dilut
Earnings Per Share - Anti-dilutive Securities (Details) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Anti-dilutive securities outstanding that were excluded from the computation | ||||
Antidilutive securities | 1,200 | 2,400 | 1,200 | 2,385 |
Stock options | ||||
Anti-dilutive securities outstanding that were excluded from the computation | ||||
Antidilutive securities | 181 | 245 | ||
Warrants - employee | ||||
Anti-dilutive securities outstanding that were excluded from the computation | ||||
Antidilutive securities | 582 | 1,350 | ||
Warrants - non employee | ||||
Anti-dilutive securities outstanding that were excluded from the computation | ||||
Antidilutive securities | 437 | 437 | ||
Shares issuable upon conversion of convertible debt | ||||
Anti-dilutive securities outstanding that were excluded from the computation | ||||
Antidilutive securities | 353 |
Liquidity - Additional Informat
Liquidity - Additional Information (Details) $ in Thousands | Dec. 31, 2018Facility | Sep. 20, 2018USD ($) | Sep. 06, 2018USD ($) | May 18, 2018USD ($) | Feb. 15, 2018USD ($)PropertyAction | Sep. 30, 2018USD ($)Facility | Sep. 30, 2017USD ($) | Sep. 05, 2018 | Jul. 18, 2018 | Jul. 06, 2018 | May 10, 2018 | Dec. 31, 2017USD ($) |
Management's plan for increasing liquidity | ||||||||||||
Unrestricted cash | $ 1,900 | |||||||||||
Positive cash flow from continuing operations | 1,321 | $ 4,515 | ||||||||||
Total current liabilities | 34,466 | $ 19,498 | ||||||||||
Total current assets | 4,972 | 4,704 | ||||||||||
Current portion of debt | 25,700 | |||||||||||
Total indebtedness | $ 80,908 | $ 73,102 | ||||||||||
Debt instrument, maturity date | Aug. 15, 2020 | |||||||||||
Number of professional and general liability actions | Action | 25 | |||||||||||
Amount repaid in accordance with the terms of the notes | $ 7,700 | |||||||||||
Stated (default) interest rate on loans | 12.50% | 10.00% | ||||||||||
Number of facilities in arrears on rent payment | Facility | 8 | |||||||||||
Combined cash rent payments of facilities for which default notices for unpaid rent have been issued per month | $ 400 | |||||||||||
Percentage of monthly combined cash rental payments for seven facilities to anticipated monthly rental receipts | 21.00% | |||||||||||
Lease receivable | $ 176,043 | |||||||||||
Symmetry Health Care | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Decrease in annualized rent | $ 600 | |||||||||||
Rent arrears waive off | 200 | |||||||||||
Monthly rent payments | $ 100 | 100 | ||||||||||
Lease receivable | 600 | |||||||||||
Pinecone | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Current portion of debt | 19,300 | |||||||||||
Debt agreement, tail fee | 500 | |||||||||||
Deferred financing cost, current | $ 100 | |||||||||||
Principal amount of the debt instrument | $ 16,250 | |||||||||||
Refinanced, amount | $ 8,700 | |||||||||||
Number of skilled nursing properties | Property | 3 | |||||||||||
Surplus cash refundable amount | $ 6,300 | |||||||||||
Cash deposited into escrow | 2,400 | |||||||||||
Proceeds from cash surplus amount | 2,400 | |||||||||||
Stated (default) interest rate on loans | 12.50% | |||||||||||
Amount of collateral subject to foreclosure | $ 5,200 | |||||||||||
Pinecone | Convertible Debt | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Amount repaid in accordance with the terms of the notes | $ 1,500 | |||||||||||
Quail Creek | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Debt instrument, maturity date | Apr. 30, 2019 | |||||||||||
Quail Creek | Congressional Bank | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Debt instrument, maturity date | Apr. 30, 2019 | |||||||||||
Senior debt-other mortgage indebtedness | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Current portion of debt | $ 900 | |||||||||||
Senior debt-other mortgage indebtedness | Quail Creek | Congressional Bank | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Current portion of debt | 4,100 | |||||||||||
Other Routine Debt | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Current portion of debt | 1,400 | |||||||||||
Debt repayments of principal in next 12 months, amortization | 2,400 | |||||||||||
Other Non-routine Debt | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Debt repayments of principal in next 12 months, amortization | 800 | |||||||||||
Forbearance Agreement | Pinecone | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Forbearance agreement | $ 400 | |||||||||||
Agreement termination date | Jul. 6, 2018 | |||||||||||
Stated (default) interest rate on loans | 13.50% | 18.50% | 5.00% | |||||||||
New Forbearance Agreement | Pinecone | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Agreement termination date | Dec. 31, 2018 | |||||||||||
Finance fee payable on repayment before 31st December 2018 | $ 250 | |||||||||||
Finance fee payable on repayment after 31st December 2018 | 500 | |||||||||||
Increase in outstanding balance for meeting unpaid expenses and interest | 700 | |||||||||||
Non-refundable additional interest payment, related with forbearance fee. | $ 1,500 | |||||||||||
Stated (default) interest rate on loans | 13.50% | 18.50% | ||||||||||
Working Capital | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Working capital deficit | 29,500 | |||||||||||
Ohio | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Lease receivable | $ 1,800 | |||||||||||
Ohio | Beacon Health Management, LLC | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Number of facilities for which default notices for unpaid rent have been issued | Facility | 5 | |||||||||||
Ohio | Scenario Forecast | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Number of facilities assumed to be operational | Facility | 5 | |||||||||||
North Carolina | Symmetry Health Care | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Number of facilities for which default notices for unpaid rent have been issued | Facility | 1 | |||||||||||
South Carolina | Symmetry Health Care | ||||||||||||
Management's plan for increasing liquidity | ||||||||||||
Number of facilities for which default notices for unpaid rent have been issued | Facility | 2 |
Cash and Restricted Cash - Sche
Cash and Restricted Cash - Schedule of Cash and Restricted Cash (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 | Sep. 30, 2017 | Dec. 31, 2016 |
Restricted Cash And Investments [Abstract] | ||||
Cash | $ 1,884 | $ 1,818 | ||
Restricted cash: | ||||
Cash collateral | 44 | 63 | ||
Replacement reserves | 297 | 260 | ||
Escrow deposits | 768 | 637 | ||
Total current portion | 1,109 | 960 | ||
Restricted cash for debt obligations | 365 | 405 | ||
HUD and other replacement reserves | 2,265 | 2,176 | ||
Total noncurrent portion | 2,630 | 2,581 | ||
Total restricted cash | 3,739 | 3,541 | ||
Total cash and restricted cash | $ 5,623 | $ 5,359 | $ 4,655 | $ 19,509 |
Property and Equipment - Schedu
Property and Equipment - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2018 | Dec. 31, 2017 | |
Property, Plant and Equipment | ||
Property and equipment, gross | $ 103,626 | $ 104,855 |
Less: accumulated depreciation and amortization | (25,052) | (23,642) |
Property and equipment, net | 78,574 | 81,213 |
Buildings and Improvements | ||
Property, Plant and Equipment | ||
Property and equipment, gross | $ 89,624 | 89,665 |
Buildings and Improvements | Minimum | ||
Property, Plant and Equipment | ||
Useful lives | 5 years | |
Buildings and Improvements | Maximum | ||
Property, Plant and Equipment | ||
Useful lives | 40 years | |
Equipment | ||
Property, Plant and Equipment | ||
Property and equipment, gross | $ 9,634 | 10,893 |
Equipment | Minimum | ||
Property, Plant and Equipment | ||
Useful lives | 2 years | |
Equipment | Maximum | ||
Property, Plant and Equipment | ||
Useful lives | 10 years | |
Land | ||
Property, Plant and Equipment | ||
Property and equipment, gross | $ 4,137 | 4,248 |
Construction in Process | ||
Property, Plant and Equipment | ||
Property and equipment, gross | $ 231 | $ 49 |
Property and Equipment - Sche_2
Property and Equipment - Schedule of Total Depreciation and Amortization of Property and Equipment (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Dec. 31, 2017 | |
Property Plant And Equipment [Abstract] | |||||
Depreciation | $ 788 | $ 857 | $ 2,394 | $ 2,486 | |
Amortization | 338 | 336 | 1,113 | 1,013 | $ 1,113 |
Total depreciation and amortization expense | $ 1,126 | $ 1,193 | $ 3,507 | $ 3,499 |
Intangible Assets and Goodwil_2
Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Dec. 31, 2017 | |
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items] | |||||
Finite and indefinite lived intangible assets, gross | $ 32,463 | $ 32,463 | $ 32,463 | ||
Finite and indefinite lived intangible assets, accumulated amortization | (10,273) | (10,273) | (9,160) | ||
Intangible assets, net carrying amount | 22,190 | 22,190 | 23,303 | ||
Amortization expense | (338) | $ (336) | (1,113) | $ (1,013) | (1,113) |
Bed Licenses Separable | |||||
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items] | |||||
Finite and indefinite lived intangible assets, gross | 2,471 | 2,471 | 2,471 | ||
Intangible assets, net carrying amount | 2,471 | 2,471 | 2,471 | ||
Bed Licenses Included In Property And Equipment | |||||
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items] | |||||
Finite and indefinite lived intangible assets, gross | 22,811 | 22,811 | 22,811 | ||
Finite and indefinite lived intangible assets, accumulated amortization | (4,678) | (4,678) | (4,166) | ||
Intangible assets, net carrying amount | 18,133 | 18,133 | 18,645 | ||
Amortization expense | (171) | (169) | (512) | (512) | (512) |
Lease Agreements | |||||
Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items] | |||||
Finite and indefinite lived intangible assets, gross | 7,181 | 7,181 | 7,181 | ||
Finite and indefinite lived intangible assets, accumulated amortization | (5,595) | (5,595) | (4,994) | ||
Intangible assets, net carrying amount | 1,586 | 1,586 | 2,187 | ||
Amortization expense | $ (167) | $ (167) | $ (601) | $ (501) | $ (601) |
Intangible Assets and Goodwil_3
Intangible Assets and Goodwill - Schedule of Total Amortization Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Dec. 31, 2017 | |
Finite-Lived Intangible Assets [Line Items] | |||||
Amortization | $ 338 | $ 336 | $ 1,113 | $ 1,013 | $ 1,113 |
Bed Licenses Included In Property And Equipment | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Amortization | 171 | 169 | 512 | 512 | 512 |
Lease Agreements | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Amortization | $ 167 | $ 167 | $ 601 | $ 501 | $ 601 |
Intangible Assets and Goodwil_4
Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense for All Definite Lived Intangibles (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Finite-Lived Intangible Assets [Line Items] | ||
Total expected amortization expense | $ 1,586 | $ 2,187 |
Bed Licenses Included In Property And Equipment | ||
Finite-Lived Intangible Assets [Line Items] | ||
2,018 | 171 | |
2,019 | 683 | |
2,020 | 683 | |
2,021 | 683 | |
2,022 | 683 | |
Thereafter | 15,230 | |
Total expected amortization expense | 18,133 | |
Lease Agreements | ||
Finite-Lived Intangible Assets [Line Items] | ||
2,018 | 166 | |
2,019 | 667 | |
2,020 | 482 | |
2,021 | 203 | |
2,022 | 68 | |
Total expected amortization expense | $ 1,586 |
Intangible Assets and Goodwil_5
Intangible Assets and Goodwill - Summary of the Changes in the Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Goodwill And Intangible Assets Disclosure [Abstract] | ||
Goodwill | $ 2,945 | $ 2,945 |
Accumulated impairment losses | (840) | (840) |
Net carrying amount | $ 2,105 | $ 2,105 |
Leases - Operating Leases - Add
Leases - Operating Leases - Additional Information (Details) | 3 Months Ended | 9 Months Ended | |
Sep. 30, 2018USD ($) | Sep. 30, 2018USD ($)Facility | Sep. 30, 2017USD ($) | |
Operating Leased Assets [Line Items] | |||
Number of skilled nursing facilities under non-cancelable operating leases | Facility | 11 | ||
Rent expense outflow | $ 301,000 | $ 440,000 | |
Georgia | |||
Operating Leased Assets [Line Items] | |||
Minimum required tangible net worth | $ 5,000,000 | 5,000,000 | |
Tangible net worth achieved | 2,700,000 | 2,700,000 | |
Annual cash inflow | $ 2,200,000 | ||
Rent expense outflow | $ 2,000,000 | ||
Lease agreement expiration year | 2,025 |
Leases - Schedule of Future Min
Leases - Schedule of Future Minimum Lease Payments (Details) $ in Thousands | Sep. 30, 2018USD ($) |
Future minimum lease payments | |
2,018 | $ 2,118 |
2,019 | 8,526 |
2,020 | 8,677 |
2,021 | 8,830 |
2,022 | 9,026 |
Thereafter | 37,430 |
Total | $ 74,607 |
Leases - Leased and Subleased F
Leases - Leased and Subleased Facilities to Third-Party Operators - Additional Information (Details) | Sep. 20, 2018USD ($) | Apr. 24, 2018USD ($)Facility | Apr. 06, 2017USD ($) | Feb. 05, 2016USD ($) | Feb. 03, 2016Facility | Aug. 01, 2015USD ($) | Mar. 31, 2018USD ($) | Sep. 30, 2018USD ($)Facilitybed | Sep. 30, 2017USD ($) | Oct. 12, 2018USD ($) | Jun. 27, 2018bed | Dec. 31, 2017USD ($) | Sep. 26, 2016USD ($) |
Operating Leased Assets [Line Items] | |||||||||||||
Number of skilled nursing facilities under non-cancelable operating leases | Facility | 11 | ||||||||||||
Number of sublease agreements executed | Facility | 27 | ||||||||||||
Number of sublease agreements executed, owned by company | Facility | 14 | ||||||||||||
Straight line rent asset | $ (1,784,000) | $ (2,138,000) | |||||||||||
Lease receivable | 176,043,000 | ||||||||||||
Long-term debt current | 25,744,000 | $ 8,090,000 | |||||||||||
Mountain Trace Facility | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Straight line rent asset | $ 500,000 | ||||||||||||
Skyline Lease | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Amount of asset purchase agreement | $ 55,000,000 | ||||||||||||
Proceeds from sale of property and equipment | 52,000,000 | ||||||||||||
Financing receivable, Net | $ 3,000,000 | ||||||||||||
Initial lease term expiration date | Mar. 31, 2022 | ||||||||||||
Long-term LOC | $ 3,000,000 | ||||||||||||
Skyline Lease | Subsequent Event | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Long-term LOC | $ 3,000,000 | ||||||||||||
Amount received from third party | $ 1,000,000 | ||||||||||||
Skyline Lease | Arkansas Leases and Facilities | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Number of sublease agreements executed | Facility | 9 | ||||||||||||
Beacon Health Management, LLC | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Number of skilled nursing facilities under non-cancelable operating leases | Facility | 1 | ||||||||||||
Number of sublease agreements executed | Facility | 5 | ||||||||||||
Number of sublease agreements executed, owned by company | Facility | 4 | ||||||||||||
Lease inducement fee paid | $ 600,000 | ||||||||||||
Lease inducement receivable outstanding | $ 500,000 | ||||||||||||
Straight line rent asset | $ 700,000 | ||||||||||||
Straight-line rent asset lease inducement on allowance | $ 500,000 | ||||||||||||
Straight-line rent asset Lease Inducement on other receivables | $ 300,000 | ||||||||||||
Symmetry Health Care | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Lease agreement expiration year | 2,030 | ||||||||||||
Lease receivable | $ 600,000 | ||||||||||||
Monthly rent payments | $ 100,000 | 100,000 | |||||||||||
Annualized rent concession granted | 644,000 | ||||||||||||
Symmetry Health Care | Mountain Trace Facility | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Number of beds in skilled nursing facility | bed | 106 | ||||||||||||
Lease receivable | 200,000 | ||||||||||||
Rent arrear waived off | $ 200,000 | ||||||||||||
Symmetry Health Care | Sumter Facility | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Number of beds in skilled nursing facility | bed | 96 | ||||||||||||
Lease receivable | 300,000 | ||||||||||||
Symmetry Health Care | Georgetown Facility | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Number of beds in skilled nursing facility | bed | 84 | ||||||||||||
Lease receivable | 50,000 | ||||||||||||
Rent receivable amount at risk | 1,300 | ||||||||||||
Peach Health Care | Variable Interest Entity, Not Primary Beneficiary | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Loans receivable | $ 1,000,000 | ||||||||||||
LOC fixed interest rate | 13.50% | ||||||||||||
Increase (decrease) in interest rate | 1.00% | ||||||||||||
Term of note | 1 year | ||||||||||||
Long-term debt current | $ 2,500,000 | $ 1,750,000 | |||||||||||
Peach Health Care | Variable Interest Entity, Not Primary Beneficiary | Peach Health Sublessee | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Long-term LOC | $ 1,000,000 | ||||||||||||
LOC fixed interest rate | 13.50% | ||||||||||||
Increase (decrease) in interest rate | 1.00% | ||||||||||||
Short-term debt | $ 800,000 | ||||||||||||
Period of extension option | 6 months | ||||||||||||
Maximum period obligations under guaranty ceases | 4 years | ||||||||||||
Period of amortization schedule | 18 months | ||||||||||||
Peach Health Care | Oceanside | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Number of beds in skilled nursing facility | bed | 85 | ||||||||||||
Peach Health Care | Savannah Beach | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Number of beds in skilled nursing facility | bed | 50 | ||||||||||||
Peach Health Care | Jeffersonville | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Number of beds in skilled nursing facility | bed | 131 | ||||||||||||
Third Party Operators | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Number of sublease agreements executed, owned by company | Facility | 16 | ||||||||||||
CIBC | Subordinated Debt | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Principal amount | $ 6,000,000 | ||||||||||||
CIBC | Skyline Lease | Subordinated Debt | |||||||||||||
Operating Leased Assets [Line Items] | |||||||||||||
Principal amount | $ 45,600,000 |
Leases - Schedule of Future M_2
Leases - Schedule of Future Minimum Payments Recievable for Operating Lease (Details) $ in Thousands | 9 Months Ended |
Sep. 30, 2018USD ($)bed | |
Covington Care | |
Operating Leased Assets [Line Items] | |
Operating Beds/Units | bed | 94 |
Structure | Leased |
Initial Lease Term Commencement Date | Aug. 1, 2015 |
Initial lease term expiration date | Apr. 30, 2025 |
Annual rent, per agreement | $ | $ 818 |
Annual Rent % of Total Expected | 3.70% |
Eaglewood ALF | |
Operating Leased Assets [Line Items] | |
Operating Beds/Units | bed | 80 |
Structure | Owned |
Initial Lease Term Commencement Date | Aug. 1, 2015 |
Initial lease term expiration date | Jul. 31, 2025 |
Annual rent, per agreement | $ | $ 764 |
Annual Rent % of Total Expected | 3.40% |
Eaglewood Care Center | |
Operating Leased Assets [Line Items] | |
Operating Beds/Units | bed | 99 |
Structure | Owned |
Initial Lease Term Commencement Date | Aug. 1, 2015 |
Initial lease term expiration date | Jul. 31, 2025 |
Annual rent, per agreement | $ | $ 764 |
Annual Rent % of Total Expected | 3.40% |
Hearth And Care Of Greenfield | |
Operating Leased Assets [Line Items] | |
Operating Beds/Units | bed | 50 |
Structure | Owned |
Initial Lease Term Commencement Date | Aug. 1, 2015 |
Initial lease term expiration date | Jul. 31, 2025 |
Annual rent, per agreement | $ | $ 382 |
Annual Rent % of Total Expected | 1.70% |
The Pavilion Care Center | |
Operating Leased Assets [Line Items] | |
Operating Beds/Units | bed | 50 |
Structure | Owned |
Initial Lease Term Commencement Date | Aug. 1, 2015 |
Initial lease term expiration date | Jul. 31, 2025 |
Annual rent, per agreement | $ | $ 382 |
Annual Rent % of Total Expected | 1.70% |
Ohio | |
Operating Leased Assets [Line Items] | |
Operating Beds/Units | bed | 373 |
Annual rent, per agreement | $ | $ 3,110 |
Annual Rent % of Total Expected | 13.90% |
Leases - Schedule of Net of All
Leases - Schedule of Net of Allowance and Annualized Cash Under Lease Agreement (Details) - Symmetry Health Care $ in Thousands | 9 Months Ended |
Sep. 30, 2018USD ($) | |
Lessor Lease Description [Line Items] | |
Straight-Line Rent Asset | $ 753 |
Other Receivables | 516 |
2018 Original Cash Annual Rent | $ 1,916 |
% of Total Original Expected 2018 Cash Annual Rent | 8.60% |
Annualized rent concession granted | $ 644 |
North Carolina | Mountain Trace | |
Lessor Lease Description [Line Items] | |
2018 Original Cash Annual Rent | $ 742 |
% of Total Original Expected 2018 Cash Annual Rent | 3.30% |
Annualized rent concession granted | $ 382 |
South Carolina | Sumter | |
Lessor Lease Description [Line Items] | |
Straight-Line Rent Asset | 537 |
Other Receivables | 409 |
2018 Original Cash Annual Rent | $ 836 |
% of Total Original Expected 2018 Cash Annual Rent | 3.80% |
Annualized rent concession granted | $ 236 |
South Carolina | Georgetown | |
Lessor Lease Description [Line Items] | |
Straight-Line Rent Asset | 216 |
Other Receivables | 107 |
2018 Original Cash Annual Rent | $ 338 |
% of Total Original Expected 2018 Cash Annual Rent | 1.50% |
Annualized rent concession granted | $ 26 |
Leases - Schedule of Future M_3
Leases - Schedule of Future Minimum Rental Payments Receivable for Operating Leases (Details) $ in Thousands | Sep. 30, 2018USD ($) |
Operating Leases Future Minimum Payments Receivable [Abstract] | |
2,018 | $ 4,660 |
2,019 | 18,610 |
2,020 | 19,040 |
2,021 | 19,515 |
2,022 | 20,002 |
Thereafter | 94,216 |
Total | $ 176,043 |
Accrued Expenses and Other - Sc
Accrued Expenses and Other - Schedule of Accrued Expenses (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Payables And Accruals [Abstract] | ||
Accrued employee benefits and payroll-related | $ 309 | $ 290 |
Real estate and other taxes | 704 | 423 |
Self-insured reserve | 1,832 | 5,077 |
Accrued interest | 401 | 260 |
Other accrued expenses | 974 | 972 |
Total accrued expenses and other | $ 4,220 | $ 7,022 |
Accrued Expenses and Other - _2
Accrued Expenses and Other - Schedule of Accrued Expenses (Parenthetical) (Details) $ in Millions | Dec. 31, 2017USD ($) |
Other Liabilities | |
Payables And Accruals [Line Items] | |
Self-insured reserve | $ 0.2 |
Notes Payable and Other Debt -
Notes Payable and Other Debt - Summary of Debt (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Debt Instrument [Line Items] | ||
Debt instrument, outstanding amount | $ 82,740 | $ 75,306 |
Deferred financing costs | (1,665) | (2,027) |
Unamortized discount on bonds | (167) | (177) |
Total debt | 80,908 | 73,102 |
Less: current portion of debt | 25,744 | 8,090 |
Notes payable and other debt, net of current portion | 55,164 | 65,012 |
Senior debt - guaranteed by HUD | ||
Debt Instrument [Line Items] | ||
Debt instrument, outstanding amount | 33,066 | 33,685 |
Senior debt - guaranteed by USDA | ||
Debt Instrument [Line Items] | ||
Debt instrument, outstanding amount | 13,831 | 20,320 |
Senior debt - guaranteed by SBA | ||
Debt Instrument [Line Items] | ||
Debt instrument, outstanding amount | 673 | 2,210 |
Senior debt Bonds, net of discount | ||
Debt Instrument [Line Items] | ||
Debt instrument, outstanding amount | 6,960 | 7,055 |
Senior Debt - Other Mortgage Indebtedness | ||
Debt Instrument [Line Items] | ||
Debt instrument, outstanding amount | 27,398 | 9,486 |
Other debt | ||
Debt Instrument [Line Items] | ||
Debt instrument, outstanding amount | $ 812 | 1,050 |
Convertible debt issued in 2014 | ||
Debt Instrument [Line Items] | ||
Debt instrument, outstanding amount | $ 1,500 |
Notes Payable and Other Debt _2
Notes Payable and Other Debt - Details of Long-term Debt (Details) - USD ($) $ in Thousands | 9 Months Ended | |||||
Sep. 30, 2018 | May 18, 2018 | May 10, 2018 | Feb. 15, 2018 | Dec. 31, 2017 | Dec. 31, 2013 | |
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Aug. 15, 2020 | |||||
Fixed interest rate (as a percent) | 12.50% | 10.00% | ||||
Debt instrument, outstanding amount | $ 82,740 | $ 75,306 | ||||
Senior debt - guaranteed by HUD | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 33,066 | 33,685 | ||||
Senior debt - guaranteed by USDA | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 13,831 | 20,320 | ||||
Senior debt - guaranteed by SBA | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 673 | 2,210 | ||||
Senior debt Bonds, net of discount | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 6,960 | 7,055 | ||||
Senior debt-other mortgage indebtedness | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 27,398 | 9,486 | ||||
Senior Debt Obligations | Senior debt - guaranteed by HUD | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 33,066 | 33,685 | ||||
Senior Debt Obligations | Senior debt - guaranteed by USDA | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 13,831 | 20,320 | ||||
Senior Debt Obligations | Senior debt - guaranteed by SBA | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 673 | 2,210 | ||||
Bonds | Senior debt Bonds, net of discount | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 6,960 | 7,055 | ||||
Other debt | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | $ 812 | 1,050 | ||||
Convertible Debt | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 1,500 | |||||
Convertible Debt | Convertible Subordinated Promissory Notes Issued in July 2012 | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Apr. 30, 2018 | |||||
Fixed interest rate (as a percent) | 14.00% | |||||
Debt instrument, outstanding amount | 1,500 | |||||
Quail Creek | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Apr. 30, 2019 | |||||
Red Mortgage | The Pavilion Care Center | Senior Debt Obligations | Senior debt - guaranteed by HUD | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Dec. 1, 2027 | |||||
Fixed interest rate (as a percent) | 4.16% | |||||
Debt instrument, outstanding amount | $ 1,247 | 1,329 | ||||
Red Mortgage | Hearth And Care Of Greenfield | Senior Debt Obligations | Senior debt - guaranteed by HUD | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Aug. 1, 2038 | |||||
Fixed interest rate (as a percent) | 4.20% | |||||
Debt instrument, outstanding amount | $ 2,078 | 2,127 | ||||
Midland State Bank | Woodland Manor | Senior Debt Obligations | Senior debt - guaranteed by HUD | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Oct. 1, 2044 | |||||
Fixed interest rate (as a percent) | 3.75% | |||||
Debt instrument, outstanding amount | $ 5,246 | 5,334 | ||||
Midland State Bank | Glenvue H&R | Senior Debt Obligations | Senior debt - guaranteed by HUD | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Oct. 1, 2044 | |||||
Fixed interest rate (as a percent) | 3.75% | |||||
Debt instrument, outstanding amount | $ 8,145 | 8,283 | ||||
Midland State Bank | Georgetown Health | Senior Debt Obligations | Senior debt - guaranteed by HUD | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Oct. 1, 2046 | |||||
Fixed interest rate (as a percent) | 2.98% | |||||
Debt instrument, outstanding amount | $ 3,584 | 3,644 | ||||
KeyBank | Other debt | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Aug. 2, 2019 | |||||
Fixed interest rate (as a percent) | 0.00% | |||||
Debt instrument, outstanding amount | $ 495 | 495 | ||||
KeyBank | Autumn Breeze | Senior Debt Obligations | Senior debt - guaranteed by HUD | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Jan. 1, 2045 | |||||
Fixed interest rate (as a percent) | 3.65% | |||||
Debt instrument, outstanding amount | $ 7,081 | 7,199 | ||||
KeyBank | Sumter Valley | Senior Debt Obligations | Senior debt - guaranteed by HUD | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Jan. 1, 2047 | |||||
Fixed interest rate (as a percent) | 3.70% | |||||
Debt instrument, outstanding amount | $ 5,685 | 5,769 | ||||
Metro City Bank | Attalla Health Care | Senior Debt Obligations | Senior debt - guaranteed by USDA | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Sep. 30, 2035 | |||||
Effective interest rate (as a percent) | 5.50% | |||||
Debt instrument, outstanding amount | 6,169 | |||||
Metro City Bank | Attalla Health Care | Senior Debt Obligations | Senior debt - guaranteed by USDA | Prime Rate | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread | 1.50% | |||||
Metro City Bank | Coosa Valley Health Care | Senior Debt Obligations | Senior debt - guaranteed by USDA | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Sep. 30, 2035 | |||||
Effective interest rate (as a percent) | 6.75% | |||||
Debt instrument, outstanding amount | $ 5,431 | 5,562 | ||||
Metro City Bank | Coosa Valley Health Care | Senior Debt Obligations | Senior debt - guaranteed by USDA | Prime Rate | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread | 1.50% | |||||
Community Bank | Mountain Trace Rehab | Senior Debt Obligations | Senior debt - guaranteed by USDA | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Jan. 24, 2036 | |||||
Effective interest rate (as a percent) | 7.00% | |||||
Debt instrument, outstanding amount | $ 4,166 | 4,260 | ||||
Community Bank | Mountain Trace Rehab | Senior Debt Obligations | Senior debt - guaranteed by USDA | Prime Rate | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread | 1.75% | |||||
Bank of Atlanta | Southland Healthcare | Senior Debt Obligations | Senior debt - guaranteed by USDA | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Jul. 27, 2036 | |||||
Effective interest rate (as a percent) | 6.75% | |||||
Debt instrument, outstanding amount | $ 4,234 | 4,329 | ||||
Bank of Atlanta | Southland Healthcare | Senior Debt Obligations | Senior debt - guaranteed by USDA | Prime Rate | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread | 1.50% | |||||
Bank of Atlanta | Southland Healthcare | Senior Debt Obligations | Senior debt - guaranteed by SBA | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Jul. 27, 2036 | |||||
Effective interest rate (as a percent) | 7.50% | |||||
Debt instrument, outstanding amount | $ 673 | 687 | ||||
Bank of Atlanta | Southland Healthcare | Senior Debt Obligations | Senior debt - guaranteed by SBA | Prime Rate | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread | 2.25% | |||||
CDC [Member] | College Park | Senior Debt Obligations | Senior debt - guaranteed by SBA | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Oct. 1, 2031 | |||||
Fixed interest rate (as a percent) | 2.81% | |||||
Debt instrument, outstanding amount | 1,523 | |||||
City of Springfield | Eaglewood Care Center | Bonds | Bonds Series A | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | May 1, 2042 | |||||
Fixed interest rate (as a percent) | 7.65% | |||||
Debt instrument, outstanding amount | $ 6,610 | 6,610 | ||||
City of Springfield | Eaglewood Care Center | Bonds | Bonds Series B | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | May 1, 2021 | |||||
Fixed interest rate (as a percent) | 8.50% | |||||
Debt instrument, outstanding amount | $ 350 | 445 | ||||
Congressional Bank | Quail Creek | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Apr. 30, 2019 | |||||
Effective interest rate (as a percent) | 5.75% | |||||
Congressional Bank | Quail Creek | Senior debt-other mortgage indebtedness | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | $ 4,136 | 4,314 | ||||
First Commercial Bank | Northwest | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Jul. 31, 2020 | |||||
Effective interest rate (as a percent) | 5.00% | |||||
First Commercial Bank | Northwest | Senior debt-other mortgage indebtedness | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | 1,122 | |||||
Exchange Bank of Alabama | Meadowood | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | May 1, 2022 | |||||
Effective interest rate (as a percent) | 4.50% | |||||
Exchange Bank of Alabama | Meadowood | Senior debt-other mortgage indebtedness | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | $ 3,951 | 4,050 | ||||
Pinecone | ||||||
Debt Instrument [Line Items] | ||||||
Fixed interest rate (as a percent) | 12.50% | |||||
Pinecone | Attalla Health Care | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Aug. 15, 2020 | |||||
Effective interest rate (as a percent) | 13.50% | |||||
Pinecone | Attalla Health Care | Senior debt-other mortgage indebtedness | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | $ 8,705 | |||||
Pinecone | College Park | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Aug. 15, 2020 | |||||
Effective interest rate (as a percent) | 13.50% | |||||
Pinecone | College Park | Senior debt-other mortgage indebtedness | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | $ 2,727 | |||||
Pinecone | Northwest | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Aug. 15, 2020 | |||||
Effective interest rate (as a percent) | 13.50% | |||||
Pinecone | Northwest | Senior debt-other mortgage indebtedness | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | $ 2,685 | |||||
Pinecone | AdCare Property Holdings, LLC | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Aug. 15, 2020 | |||||
Effective interest rate (as a percent) | 13.50% | |||||
Pinecone | AdCare Property Holdings, LLC | Senior debt-other mortgage indebtedness | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, outstanding amount | $ 5,194 | |||||
First Insurance Funding | Other debt | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Mar. 1, 2019 | |||||
Fixed interest rate (as a percent) | 4.24% | |||||
Debt instrument, outstanding amount | $ 81 | 20 | ||||
Mc Bride | Other debt | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Sep. 30, 2019 | |||||
Fixed interest rate (as a percent) | 4.00% | |||||
Debt instrument, outstanding amount | $ 153 | 264 | ||||
Pharmacy Care of Arkansas | Other debt | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Feb. 8, 2018 | |||||
Fixed interest rate (as a percent) | 2.00% | |||||
Debt instrument, outstanding amount | 42 | |||||
South Carolina Department of Health & Human Services | Other debt | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, maturity date | Feb. 24, 2019 | |||||
Fixed interest rate (as a percent) | 5.75% | |||||
Debt instrument, outstanding amount | $ 83 | $ 229 | $ 400 |
Notes Payable and Other Debt _3
Notes Payable and Other Debt - Details of Long-term Debt (Parenthetical) (Details) $ in Thousands | 9 Months Ended | ||||
Sep. 30, 2018USD ($)Facility | May 18, 2018 | Feb. 15, 2018 | Dec. 31, 2017USD ($) | Dec. 31, 2013USD ($) | |
Debt Instrument [Line Items] | |||||
Number of skilled nursing facilities | Facility | 2 | ||||
Finance fee percentage on loans including charge added per forbearance agreement | 5.50% | ||||
Fixed interest rate (as a percent) | 12.50% | 10.00% | |||
Debt instrument, outstanding amount | $ 82,740 | $ 75,306 | |||
Other debt | |||||
Debt Instrument [Line Items] | |||||
Debt instrument, outstanding amount | $ 812 | 1,050 | |||
South Carolina Department of Health & Human Services | Other debt | |||||
Debt Instrument [Line Items] | |||||
Number of skilled nursing facilities | Facility | 2 | ||||
Fixed interest rate (as a percent) | 5.75% | ||||
Debt instrument, outstanding amount | $ 83 | 229 | $ 400 | ||
Term of note | 2 years | ||||
Senior debt - guaranteed by HUD | |||||
Debt Instrument [Line Items] | |||||
Number of skilled nursing facilities | Facility | 7 | ||||
Percentage of debt insured | 100.00% | ||||
Debt instrument, outstanding amount | $ 33,066 | 33,685 | |||
Senior debt - guaranteed by USDA | |||||
Debt Instrument [Line Items] | |||||
Number of skilled nursing facilities | Facility | 4 | ||||
Annual renewal fee for the USDA guarantee (as a percent) | 0.25% | ||||
Prepayment penalties, annual decline capped (as a percent) | 1.00% | ||||
Prepayment penalties declining percentage capped, period | 10 years | ||||
Prepayment penalties declining percentage capped thereafter | 0.00% | ||||
Debt instrument, outstanding amount | $ 13,831 | 20,320 | |||
Senior debt - guaranteed by SBA | |||||
Debt Instrument [Line Items] | |||||
Number of skilled nursing facilities | Facility | 2 | ||||
Percentage of debt insured | 75.00% | ||||
Debt instrument, outstanding amount | $ 673 | 2,210 | |||
Senior debt Bonds, net of discount | |||||
Debt Instrument [Line Items] | |||||
Amortization of deferred financing costs (in percentage) | 0.26% | ||||
Debt instrument, outstanding amount | $ 6,960 | 7,055 | |||
Senior debt-other mortgage indebtedness | |||||
Debt Instrument [Line Items] | |||||
Debt instrument, outstanding amount | $ 27,398 | $ 9,486 | |||
Minimum | |||||
Debt Instrument [Line Items] | |||||
Amortization of deferred financing costs (in percentage) | 0.08% | ||||
Debt Instrument Prepayment Penalties Percentage | 2.00% | ||||
Minimum | Senior debt - guaranteed by USDA | |||||
Debt Instrument [Line Items] | |||||
Percentage of debt insured | 70.00% | ||||
Minimum | Senior debt-other mortgage indebtedness | |||||
Debt Instrument [Line Items] | |||||
Amortization of deferred financing costs (in percentage) | 0.14% | ||||
Maximum | |||||
Debt Instrument [Line Items] | |||||
Amortization of deferred financing costs (in percentage) | 0.53% | ||||
Debt Instrument Prepayment Penalties Percentage | 3.00% | ||||
Maximum | Senior debt - guaranteed by USDA | |||||
Debt Instrument [Line Items] | |||||
Percentage of debt insured | 80.00% | ||||
Maximum | Senior debt-other mortgage indebtedness | |||||
Debt Instrument [Line Items] | |||||
Amortization of deferred financing costs (in percentage) | 1.49% |
Notes Payable and Other Debt _4
Notes Payable and Other Debt - Additional Information (Details) $ in Thousands | Sep. 06, 2018USD ($) | May 18, 2018 | Feb. 15, 2018USD ($)Property | Sep. 30, 2018USD ($)credit_instrument | Sep. 30, 2017USD ($) | Sep. 30, 2018USD ($)credit_instrument | Sep. 30, 2017USD ($) | Sep. 05, 2018 | Jul. 18, 2018 | Jul. 06, 2018 | May 10, 2018 |
Debt Instrument [Line Items] | |||||||||||
Loss on extinguishment of debt | $ (3,514) | $ 0 | $ (3,955) | $ (63) | |||||||
Debt instrument, maturity date | Aug. 15, 2020 | ||||||||||
Stated (default) interest rate on loans | 12.50% | 10.00% | |||||||||
Finance fee percentage on loans | 3.00% | ||||||||||
Interest rate terms of loans | is August 15, 2020 and it originally bore interest at a fixed rate equal to 10% per annum for the first three months after the Closing Date and at a fixed rate equal to 12.5% per annum thereafter, subject to adjustment upon an event of default and specified regulatory events. The Pinecone Credit Facility is secured by, among other things, first priority liens on the Facilities and all tangible and intangible assets of the borrowers owning the Facilities, including all rent payments received from the operators thereof. | ||||||||||
Number of credit related instruments | credit_instrument | 23 | 23 | |||||||||
Pinecone | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Principal amount of the debt instrument | $ 16,250 | ||||||||||
Refinanced, amount | $ 8,700 | ||||||||||
Number of skilled nursing properties | Property | 3 | ||||||||||
Loss on extinguishment of debt | $ 3,500 | ||||||||||
Stated (default) interest rate on loans | 12.50% | ||||||||||
Fixed charge coverage ratio required | 1.2 | ||||||||||
Fixed charge coverage ratio | 1 | ||||||||||
Pinecone | Forbearance Agreement | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Stated (default) interest rate on loans | 13.50% | 18.50% | 5.00% | ||||||||
Increase in outstanding principal balance of credit facility | 2.50% | ||||||||||
Agreement termination date | Jul. 6, 2018 | ||||||||||
Pinecone | New Forbearance Agreement | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Stated (default) interest rate on loans | 13.50% | 18.50% | |||||||||
Agreement termination date | Dec. 31, 2018 | ||||||||||
Finance fee payable on repayment before 31st December 2018 | $ 250 | ||||||||||
Finance fee payable on repayment after 31st December 2018 | 500 | ||||||||||
Increase in outstanding balance for meeting unpaid expenses and interest | 700 | ||||||||||
Increase in outstanding balance to settle against non-refundable payment of additional interest | $ 1,500 | ||||||||||
Pinecone | Secured Debt | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Principal amount of the debt instrument | $ 16,250 | ||||||||||
Prepayment premium percentage | 1.00% |
Notes Payable and Other Debt _5
Notes Payable and Other Debt - Summary of the Scheduled Maturities (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Debt Disclosure [Abstract] | ||
2,019 | $ 6,494 | |
2,020 | 20,940 | |
2,021 | 1,711 | |
2,022 | 5,161 | |
2,023 | 1,730 | |
Thereafter | 46,704 | |
Subtotal | 82,740 | $ 75,306 |
Less: unamortized discounts | (167) | (177) |
Less: deferred financing costs, net | (1,665) | (2,027) |
Total debt | $ 80,908 | $ 73,102 |
Notes Payable and Other Debt _6
Notes Payable and Other Debt - Summary of the Scheduled Maturities (Parenthetical) (Details) | 9 Months Ended |
Sep. 30, 2018 | |
Pinecone | |
Debt Instrument [Line Items] | |
Line of credit facility, maturity date | Aug. 15, 2020 |
Discontinued Operations - Sched
Discontinued Operations - Schedule of Operations, Assets and Liabilities of the Disposal Groups Held for Sale (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
Net loss | $ 157 | $ (1,032) | $ (242) | $ (2,049) |
Discontinued Operations | ||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||
Cost of services | (159) | 1,026 | 235 | 2,032 |
Interest expense, net | 2 | 6 | 7 | 17 |
Net loss | $ 157 | $ (1,032) | $ (242) | $ (2,049) |
Common and Preferred Stock - Ad
Common and Preferred Stock - Additional Information (Details) $ / shares in Units, $ in Millions | 1 Months Ended | 3 Months Ended | 9 Months Ended | |||
Nov. 30, 2016repurchase_programshares | Sep. 30, 2018USD ($)$ / sharesshares | Sep. 30, 2017USD ($)shares | Sep. 30, 2018USD ($)DividendsPeriodDirector$ / sharesshares | Sep. 30, 2017USD ($)$ / sharesshares | Dec. 31, 2017shares | |
Class of Stock [Line Items] | ||||||
Preferred stock, shares outstanding | 2,812,000 | 2,812,000 | 2,812,000 | |||
Preferred stock, shares issued | 2,812,000 | 2,812,000 | 2,812,000 | |||
Series A Preferred Stock | ||||||
Class of Stock [Line Items] | ||||||
Dividends paid, preferred stock | $ / shares | $ 2.72 | $ 0.68 | ||||
Preferred stock dividends | $ | $ 1.9 | $ 5.7 | ||||
Undeclared preferred stock dividends in arrears | $ | $ 7.6 | $ 1.9 | ||||
Cumulative preferential cash dividend rate | 10.875% | |||||
Stated liquidation preference | $ / shares | $ 25 | $ 25 | ||||
Number of consecutives or non consecutive dividends period | DividendsPeriod | 4 | |||||
Increase of preferred stock dividend rate | 12.875% | |||||
Number of additional directors | Director | 2 | |||||
Preferred stock, shares outstanding | 2,811,535 | 2,811,535 | ||||
Preferred stock, shares issued | 2,811,535 | 2,811,535 | ||||
Preferred stock, voting rights | no voting rights but have limited voting rights under certain circumstances. | |||||
Redemption price per share | $ / shares | $ 25 | $ 25 | ||||
November 2016 Plan | ||||||
Class of Stock [Line Items] | ||||||
Number of share repurchase programs | repurchase_program | 2 | |||||
Period of repurchase program | 12 months | |||||
November 2016 Plan | Shares of Common Stock | ||||||
Class of Stock [Line Items] | ||||||
Number of shares authorized to be repurchased | 1,000,000 | |||||
Stock repurchase program, shares | 0 | 0 | 0 | 118,199 | ||
Stock repurchase during period, value | $ | $ 0.2 | |||||
Stock repurchased, average cost per share | $ / shares | $ 1.54 | |||||
November 2016 Plan | Series A Preferred Stock | ||||||
Class of Stock [Line Items] | ||||||
Number of shares authorized to be repurchased | 100,000 | |||||
Stock repurchase program, shares | 0 | 0 |
Stock Based Compensation - Summ
Stock Based Compensation - Summary of Recognized Stock Based Compensation (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total employee stock-based compensation expense | $ 50 | $ 127 | $ 126 | $ 281 |
Employee | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total employee stock-based compensation expense | 4 | 66 | 11 | 104 |
Employee | Warrant | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total employee stock-based compensation expense | 0 | 19 | 0 | 23 |
Employee | Restricted stock | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total employee stock-based compensation expense | 4 | 47 | 11 | 81 |
Nonemployee | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total employee stock-based compensation expense | 46 | 61 | 115 | 177 |
Nonemployee | Restricted stock | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total employee stock-based compensation expense | 46 | 48 | 115 | 140 |
Nonemployee | Stock options | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total employee stock-based compensation expense | $ 0 | $ 13 | $ 0 | $ 37 |
Stock Based Compensation - Addi
Stock Based Compensation - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Number of securities remaining available for future issuance | 233,296 | 233,296 | ||
Employee stock options or warrants issued | $ 0 | $ 0 | $ 0 | $ 0 |
Restricted stock | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Unrecognized compensation expense | $ 200 | $ 200 | ||
Period of recognition of compensation expense | 1 year 8 months 12 days | |||
2011 plan | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Maximum number of shares of the company's stock that may be issued | 2,027,393 | 2,027,393 |
Stock Based Compensation - Su_2
Stock Based Compensation - Summary of Company's Stock Option Activity (Details) - Stock options - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 9 Months Ended | 12 Months Ended |
Sep. 30, 2018 | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||
Beginning balance (shares) | 181 | |
Granted (shares) | 0 | |
Forfeited (shares) | 0 | |
Expired (shares) | 0 | |
Ending balance (shares) | 181 | 181 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] | ||
Beginning balance (USD per share) | $ 3.98 | |
Granted (USD per share) | 0 | |
Forfeited (USD per share) | 0 | |
Expired (USD per share) | 0 | |
Ending balance (USD per share) | $ 3.98 | $ 3.98 |
Additional disclosures | ||
Outstanding - weighted average remaining contractual term | 6 years 4 months 24 days | |
Outstanding and Vested, September 30, 2018 | 5 years 7 months 6 days | |
Outstanding aggregate intrinsic value | $ 0 | |
Outstanding and Vested, September 30, 2018 | $ 0 |
Stock Based Compensation - Sche
Stock Based Compensation - Schedule of Exercise Price Range (Details) shares in Thousands | 9 Months Ended |
Sep. 30, 2018$ / sharesshares | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Stock options outstanding, number (shares) | shares | 181 |
Stock options outstanding, weighted average remaining contractual term (in years) | 5 years 7 months 6 days |
Stock options outstanding, weighted average exercise price (USD per share) | $ 3.98 |
Options exercisable, vested (shares) | shares | 181 |
Options exercisable, weighted average exercise price (USD per share) | $ 3.98 |
$1.31 - $3.99 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Stock options outstanding, number (shares) | shares | 115 |
Stock options outstanding, weighted average remaining contractual term (in years) | 6 years |
Stock options outstanding, weighted average exercise price (USD per share) | $ 3.90 |
Options exercisable, vested (shares) | shares | 115 |
Options exercisable, weighted average exercise price (USD per share) | $ 3.90 |
Exercise price, minimum (USD per share) | 1.31 |
Exercise price, maximum (USD per share) | $ 3.99 |
$4.00 - $4.30 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Stock options outstanding, number (shares) | shares | 66 |
Stock options outstanding, weighted average remaining contractual term (in years) | 5 years |
Stock options outstanding, weighted average exercise price (USD per share) | $ 4.12 |
Options exercisable, vested (shares) | shares | 66 |
Options exercisable, weighted average exercise price (USD per share) | $ 4.12 |
Exercise price, minimum (USD per share) | 4 |
Exercise price, maximum (USD per share) | $ 4.30 |
Stock Based Compensation - Warr
Stock Based Compensation - Warrants Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 9 Months Ended | 12 Months Ended |
Sep. 30, 2018 | Dec. 31, 2017 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Outstanding at the ending of the period (in shares) | 1,019 | |
Warrants | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Outstanding at the beginning of the period (in shares) | 1,019 | |
Granted (in shares) | 0 | |
Forfeited (in shares) | 0 | |
Expired (in shares) | 0 | |
Outstanding at the ending of the period (in shares) | 1,019 | 1,019 |
Outstanding at the beginning of the period (in dollars per share) | $ 3.79 | |
Granted (in dollars per share) | 0 | |
Forfeited (in dollars per share) | 0 | |
Expired (in dollars per share) | 0 | |
Outstanding at the ending of the period (in shares) | $ 3.79 | $ 3.79 |
Weighted average remaining contractual term (in years) | 4 years 8 months 12 days | |
Outstanding and Vested, September 30, 2018 | 3 years 10 months 24 days | |
Aggregate intrinsic value (in dollars) | $ 0 | |
Outstanding and Vested, September 30, 2018 | $ 0 |
Stock Based Compensation - Opti
Stock Based Compensation - Options and Warrants Outstanding by Exercise Price (Details) - $ / shares | 9 Months Ended | |
Sep. 30, 2018 | Dec. 31, 2017 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Warrants outstanding | 1,019,000 | |
Weighted Average Remaining Contractual Term (in years) | 3 years 10 months 24 days | |
Vested | 1,019,000 | |
Warrant | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Warrants outstanding | 1,019,000 | 1,019,000 |
Weighted Average Exercise Price (in dollars per share) | $ 3.79 | $ 3.79 |
Warrant | Employee | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 3.79 | |
Weighted Average Exercise Price (in dollars per share) | $ 3.79 | |
$2.00 - $2.99 | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Warrants outstanding | 110,000 | |
Weighted Average Remaining Contractual Term (in years) | 1 year 1 month 6 days | |
Vested | 110,000 | |
$2.00 - $2.99 | Minimum | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | $ 2 | |
$2.00 - $2.99 | Maximum | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 2.99 | |
$2.00 - $2.99 | Warrant | Employee | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 2.57 | |
Weighted Average Exercise Price (in dollars per share) | $ 2.57 | |
$3.00 - $3.99 | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Warrants outstanding | 274,000 | |
Weighted Average Remaining Contractual Term (in years) | 2 years 8 months 12 days | |
Vested | 274,000 | |
$3.00 - $3.99 | Minimum | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | $ 3 | |
$3.00 - $3.99 | Maximum | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 3.99 | |
$3.00 - $3.99 | Warrant | Employee | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 3.71 | |
Weighted Average Exercise Price (in dollars per share) | $ 3.71 | |
$0 - $1.99 | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Warrants outstanding | 110,000 | |
Weighted Average Remaining Contractual Term (in years) | 1 year 1 month 6 days | |
Vested | 110,000 | |
$0 - $1.99 | Minimum | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | $ 0 | |
$0 - $1.99 | Maximum | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 1.99 | |
$0 - $1.99 | Warrant | Employee | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 1.93 | |
Weighted Average Exercise Price (in dollars per share) | $ 1.93 | |
$4.00 - $4.99 | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Warrants outstanding | 502,000 | |
Weighted Average Remaining Contractual Term (in years) | 5 years 9 months 18 days | |
Vested | 502,000 | |
$4.00 - $4.99 | Minimum | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | $ 4 | |
$4.00 - $4.99 | Maximum | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 4.99 | |
$4.00 - $4.99 | Warrant | Employee | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 4.42 | |
Weighted Average Exercise Price (in dollars per share) | $ 4.42 | |
$5.00 - $5.90 | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Warrants outstanding | 23,000 | |
Weighted Average Remaining Contractual Term (in years) | 4 years 7 months 6 days | |
Vested | 23,000 | |
$5.00 - $5.90 | Minimum | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | $ 5 | |
$5.00 - $5.90 | Maximum | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 5.90 | |
$5.00 - $5.90 | Warrant | Employee | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Weighted Average Exercise Price (in dollars per share) | 5.90 | |
Weighted Average Exercise Price (in dollars per share) | $ 5.90 |
Stock Based Compensation - Su_3
Stock Based Compensation - Summary of Company's Restricted Stock Activity (Details) - Restricted stock shares in Thousands | 9 Months Ended |
Sep. 30, 2018$ / sharesshares | |
Number of Shares (000's) | |
Unvested at the beginning of the period (in shares) | shares | 152 |
Granted (in shares) | shares | 490 |
Vested (in shares) | shares | (61) |
Unvested at the end of the period (in shares) | shares | 581 |
Weighted Average Grant Date Fair Value | |
Unvested at the beginning of the period (in dollars per share) | $ / shares | $ 1.83 |
Granted (in dollars per share) | $ / shares | 0.30 |
Vested (in dollars per share) | $ / shares | 1.85 |
Unvested at the ending of the period (in dollars per share) | $ / shares | $ 0.54 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Details) | Apr. 02, 2018USD ($) | Mar. 28, 2018USD ($) | Mar. 12, 2018USD ($)Case | Dec. 31, 2018USD ($) | Sep. 30, 2018USD ($)Case | Jun. 30, 2018USD ($)ActionCase | Mar. 31, 2018USD ($) | Sep. 30, 2017USD ($) | Jun. 30, 2018Case | Jun. 30, 2018USD ($)Case | Sep. 30, 2018USD ($)Case | Sep. 30, 2017USD ($) | Dec. 31, 2017USD ($) | Apr. 21, 2017USD ($) | Jul. 17, 2015USD ($) |
Loss Contingencies [Line Items] | |||||||||||||||
Litigation settlement amount | $ 5,200,000 | $ 2,400,000 | |||||||||||||
Self-insured reserve | $ 1,832,000 | $ 1,832,000 | $ 5,077,000 | ||||||||||||
Bad debt expense | (48,000) | $ 0 | 3,934,000 | $ 455,000 | |||||||||||
Pinecone Credit Facility Contingent Fees | New Forbearance Agreement | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Finance fee payable on repayment before 31st December 2018 | 250,000 | ||||||||||||||
Pinecone Credit Facility Contingent Fees | New Forbearance Agreement | Scenario Forecast | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Finance fee payable on repayment after 31st December 2018 | $ 500,000 | ||||||||||||||
Internal Revenue Service | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Employer shared responsibility payment liability | $ 2,900,000 | ||||||||||||||
Variable Interest Entity, Not Primary Beneficiary | HAH Note Paid Prior to Bankruptcy | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Offer to settle claims | $ 4,700,000 | ||||||||||||||
Bad debt expense | 600,000 | ||||||||||||||
Variable Interest Entity, Not Primary Beneficiary | Notes Receivable | Aria Health Consulting LLC | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Accounts and notes receivable | $ 1,000,000 | ||||||||||||||
Other Liabilities | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Self-insured reserve | 200,000 | ||||||||||||||
Accounts payable | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Self-insured reserve | $ 600,000 | $ 600,000 | 500,000 | ||||||||||||
Pending Litigation | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Pending litigation | Case | 21 | 21 | |||||||||||||
Cases dismissed | Insurance Settlement | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Litigation settlement amount | $ 2,800,000 | ||||||||||||||
Mediation Settlement | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Litigation settlement amount | $ 500,000 | $ 3,300,000 | |||||||||||||
Other Settlements | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Number of professional and general liability cases settled | Action | 1 | ||||||||||||||
Litigation settlement amount | $ 50,000 | ||||||||||||||
Debt Instrument, Frequency of Periodic Payment | 10 monthly instalments | ||||||||||||||
Aria Bankruptcy Proceeding | Pending Litigation | Notes Receivable | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Amount moved for relief from automatic stay | $ 800,000 | ||||||||||||||
Arkansas | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Pending litigation | Case | 7 | 7 | 7 | ||||||||||||
Original number of professional and general liability cases | Case | 25 | ||||||||||||||
Case dismissed | Case | 18 | ||||||||||||||
Arkansas | Pending Litigation | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Number of professional and general liability cases settled | Case | 7 | ||||||||||||||
Number of punitive damages excluded from coverage | Case | 14 | 14 | |||||||||||||
Loss contingency claims after the company transitioned operations | Case | 5 | ||||||||||||||
Arkansas | Professional and General Liability Cases Dismissed without Prejudice | Settled Litigation | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Litigation settlement amount | $ 800,000 | ||||||||||||||
Arkansas | Pending actions covered by insurance | Pending Litigation | |||||||||||||||
Loss Contingencies [Line Items] | |||||||||||||||
Pending litigation | Case | 2 | 2 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Details) | 3 Months Ended |
Sep. 30, 2018USD ($) | |
McBride | |
Related Party Transaction [Line Items] | |
Payments to related party | $ 39,082 |
Subsequent Events - Additional
Subsequent Events - Additional Information (Details) - Skyline Lease - USD ($) $ in Millions | Oct. 12, 2018 | Apr. 24, 2018 |
Subsequent Event [Line Items] | ||
Long-term LOC | $ 3 | |
Subsequent Event | ||
Subsequent Event [Line Items] | ||
Amount accepted from third party in full satisfaction | $ 1 | |
Long-term LOC | $ 3 |